<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Ann Intensive Care</journal-id><journal-id journal-id-type="iso-abbrev">Ann Intensive Care</journal-id><journal-title-group><journal-title>Annals of Intensive Care</journal-title></journal-title-group><issn pub-type="epub">2110-5820</issn><publisher><publisher-name>Springer International Publishing</publisher-name><publisher-loc>Cham</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40394400</article-id><article-id pub-id-type="pmc">PMC12092903</article-id>
<article-id pub-id-type="publisher-id">1489</article-id><article-id pub-id-type="doi">10.1186/s13613-025-01489-1</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Association between ventilation&#x02013;perfusion matching improvement during initial prone positioning and ICU mortality in patients with moderate to severe ARDS: a prospective two-center study</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2242-6948</contrib-id><name><surname>Wang</surname><given-names>Rui</given-names></name><address><email>wangrui1985816@gmail.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Wancong</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Tang</surname><given-names>Xiao</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Qi</surname><given-names>Zhenyuan</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Ting</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Yalan</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Hongju</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Yan</surname><given-names>Jican</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Yang</surname><given-names>Hua</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Lyu</surname><given-names>Wenrui</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Zhaohong</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Sun</surname><given-names>Bing</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Gan</surname><given-names>Guifen</given-names></name><address><email>xzhd1991@163.com</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/013xs5b60</institution-id><institution-id institution-id-type="GRID">grid.24696.3f</institution-id><institution-id institution-id-type="ISNI">0000 0004 0369 153X</institution-id><institution>Department of Respiratory and Critical Care Medicine, Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital, </institution><institution>Capital Medical University, </institution></institution-wrap>No. 8 Gongren Tiyuchang Nanlu, Chaoyang District, Beijing, China </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05h33bt13</institution-id><institution-id institution-id-type="GRID">grid.262246.6</institution-id><institution-id institution-id-type="ISNI">0000 0004 1765 430X</institution-id><institution>Department of Critical Care Medicine, </institution><institution>Affiliated Hospital of Qinghai University, </institution></institution-wrap>No. 29 Tongren Road, Chengdong District, Xining, Qinghai China </aff></contrib-group><pub-date pub-type="epub"><day>21</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="pmc-release"><day>21</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>15</volume><elocation-id>69</elocation-id><history><date date-type="received"><day>9</day><month>2</month><year>2025</year></date><date date-type="accepted"><day>11</day><month>5</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article&#x02019;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#x02019;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p id="Par1">Prone positioning (PP) is widely used in patients with moderate to severe acute respiratory distress syndrome (ARDS) to reduce mortality by mitigating the risk of ventilation-induced lung injury (VILI) and enhancing ventilation-perfusion (V/Q) matching. However, patient responses to PP are variable, and the relationship between V/Q matching improvement during PP and clinical outcomes remains unclear. This study aimed to test the hypothesis that improvements in V/Q matching 4&#x000a0;h within the first PP are associated with reduced intensive care unit (ICU) mortality.</p></sec><sec><title>Methods</title><p id="Par2">In this two-center, prospective, observational study, regional ventilation and perfusion changes in patients with moderate to severe ARDS were evaluated using electrical impedance tomography (EIT) during the first PP session. Patients were categorized as responders or non-responders based on whether V/Q matching improved by &#x02265;&#x02009;10% within 4&#x000a0;h of the first PP. The primary endpoint was ICU mortality, and the secondary endpoint was ventilator-free days at day 28.</p></sec><sec><title>Results</title><p id="Par3">A total of 77 patients were included in the study, with 46 (59.7%) classified as responders and 31 (40.3%) as non-responders. EIT revealed significant improvements in V/Q matching during PP, primarily through reduced dorsal shunt and ventral dead space. These improvements were partially sustained after resupination. Responders showed significantly lower ICU mortality (28.3% vs. 51.6%; <italic>P</italic>&#x02009;=&#x02009;0.038) and more ventilator-free days at day 28 (16 [range, 0&#x02013;21] days vs. 9 [0&#x02013;15] days; <italic>P</italic>&#x02009;=&#x02009;0.024) than non-responders. Multivariate analysis confirmed enhanced V/Q matching as an independent protective factor against mortality (OR, 0.790; 95% CI, 0.681&#x02013;0.917; <italic>P</italic>&#x02009;=&#x02009;0.002).</p></sec><sec><title>Conclusions</title><p id="Par4">Improvement in V/Q matching 4&#x000a0;h within the first PP is associated with lower ICU mortality in patients with moderate to severe ARDS. These findings underscore the importance of PP in ARDS management and highlight the potential of V/Q responsiveness in guiding individualized PP strategies.</p></sec><sec><title>Trial registration</title><p id="Par5">ClinicalTrials.Gov: NCT05765760. Registered 28 February 2023.</p></sec><sec><title>Supplementary Information</title><p>The online version contains supplementary material available at 10.1186/s13613-025-01489-1.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Prone position</kwd><kwd>Acute respiratory distress syndrome</kwd><kwd>Electrical impedance tomography</kwd><kwd>Ventilation-perfusion matching</kwd><kwd>Ventilator-induced lung injury</kwd></kwd-group><funding-group><award-group><funding-source><institution>Reform and Development Program of the Beijing Institute of Respiratory Medicine</institution></funding-source><award-id>Ggyfz202413</award-id><principal-award-recipient><name><surname>Wang</surname><given-names>Rui</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution>Beijing Municipal Administration of Hospitals Incubating Program</institution></funding-source><award-id>PX2023010</award-id><principal-award-recipient><name><surname>Wang</surname><given-names>Rui</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; La Soci&#x000e9;t&#x000e9; de R&#x000e9;animation de Langue Francaise = The French Society of Intensive Care (SRLF) 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p id="Par6">Prone positioning (PP) is widely used in the treatment of moderate to severe acute respiratory distress syndrome (ARDS) because it improves oxygenation and reduces mortality [<xref ref-type="bibr" rid="CR1">1</xref>&#x02013;<xref ref-type="bibr" rid="CR3">3</xref>]. It redistributes ventilation, promotes alveolar recruitment, reduces hyperinflation, and enhances lung homogeneity, lowering the risk of ventilation-induced lung injury (VILI) [<xref ref-type="bibr" rid="CR4">4</xref>]. The recruitment of dorsal lung regions, which also receive the majority of pulmonary blood flow, improves ventilation-perfusion (V/Q) matching, thereby enhancing oxygenation [<xref ref-type="bibr" rid="CR5">5</xref>]. Previous studies have suggested that PP can improve oxygenation in 70-80% of ARDS patients; however, this benefit is not universal [<xref ref-type="bibr" rid="CR6">6</xref>&#x02013;<xref ref-type="bibr" rid="CR9">9</xref>]. Therefore, it can be inferred that PP may not improve V/Q matching in every patient. Over the years, the absence of simple bedside methods has hindered the collection of direct evidence from patients.</p><p id="Par7">Electrical impedance tomography (EIT) is a non-invasive, radiation-free, and real-time monitoring technique that precisely assesses regional ventilation and perfusion distribution [<xref ref-type="bibr" rid="CR10">10</xref>&#x02013;<xref ref-type="bibr" rid="CR12">12</xref>]. The evaluation of ventilation using EIT is already well-established. However, perfusion assessment is still relatively new and most commonly relies on using hypertonic saline as a &#x0201c;conductive&#x0201d; agent, which has been recently validated in experimental studies [<xref ref-type="bibr" rid="CR13">13</xref>&#x02013;<xref ref-type="bibr" rid="CR15">15</xref>]. This approach is efficient for monitoring dynamic responses to maneuvers such as PP, enhancing the physiological understanding and management of ARDS at the bedside [<xref ref-type="bibr" rid="CR12">12</xref>]. In theory, PP enhances V/Q matching by reducing dorsal shunt through increased ventilation in well-perfused regions while decreasing ventral dead space by lowering ventilation in poorly perfused areas [<xref ref-type="bibr" rid="CR16">16</xref>]. Few studies have explored the impact of PP on V/Q matching in ARDS patients, with limitations such as small sample sizes, a focus on the early effects of PP, and a lack of assessment of V/Q changes after returning to the supine position [<xref ref-type="bibr" rid="CR17">17</xref>&#x02013;<xref ref-type="bibr" rid="CR20">20</xref>]. Moreover, the relationship between changes in V/Q matching after PP and survival remains unclear.</p><p id="Par8">We hypothesized that enhanced V/Q matching after the first session of PP might correlate with better outcomes in patients with moderate to severe ARDS. Therefore, we conducted a prospective observational study at two centers to investigate the relationship between V/Q matching improvement 4&#x000a0;h within the first PP and intensive care unit (ICU) mortality.</p></sec><sec id="Sec2"><title>Methods</title><sec id="Sec3"><title>Study design and patients</title><p id="Par9">This prospective observational study was conducted at two tertiary hospitals in China: Beijing Chao-Yang Hospital and Qinghai University Affiliated Hospital. The research protocol received authorization from the Institutional Review Board at each participating center and was registered on ClinicalTrials.gov (NCT05765760). This study was conducted in accordance with the ethical principles outlined in the Declaration of Helsinki (2013 revised edition). Written informed consent was obtained from the legal guardians because the patients were unable to provide consent at the time of inclusion.</p><p id="Par10">We included patients who met the following criteria: (1) fulfillment of the diagnostic criteria for moderate to severe ARDS according to the Berlin definition, with a ratio of partial pressure of arterial oxygen (PaO&#x02082;) to fraction of inspired oxygen (FiO&#x02082;)&#x02009;&#x0003c;&#x02009;150&#x000a0;mm Hg under optimal mechanical ventilation [<xref ref-type="bibr" rid="CR21">21</xref>]; and (2) placement a central venous catheter in the jugular or subclavian vein for treatment based on a clinical decision at enrollment.</p><p id="Par11">Patients were excluded if they met any of the following criteria: (1) age less than 18 years; (2) pregnancy; (3) body mass index (BMI) greater than 35&#x000a0;kg/m&#x000b2;; (4) receipt of invasive mechanical ventilation (IMV) for more than 48&#x000a0;h; (5) severe hemodynamic instability (e.g., mean arterial pressure&#x02009;&#x0003c;&#x02009;65 mmHg and norepinephrine&#x02009;&#x0003e;&#x02009;0.5&#x000a0;&#x000b5;g/kg/min); (6) immediate need for venovenous extracorporeal membrane oxygenation (VV-ECMO) therapy; or (7) contraindications to PP or EIT (e.g., facial or neck trauma, spinal instability, pacemaker, implantable defibrillator, chest and abdominal skin lesions).</p></sec><sec id="Sec4"><title>Study protocol</title><p id="Par12">The following patient characteristics were collected at enrollment: age, sex, BMI, clinical scores, etiology and severity of ARDS, underlying comorbidities, duration of IMV before PP, hemodynamic status, arterial blood gas, and ventilatory variables.</p><p id="Par13">All patients received volume-controlled mechanical ventilation with standardized settings: tidal volume set at 6&#x02013;8 mL/kg of predicted body weight, respiratory rate adjusted to maintain a pH of 7.35 to 7.45, positive end-expiratory pressure (PEEP) determined after a recruitment maneuver and decremental titration to achieve the highest respiratory system compliance in the supine position and kept constant during PP, and FiO<sub>2</sub> adjusted to maintain oxygen saturation (SpO<sub>2</sub>) of 93&#x02013;96%. Plateau pressure and total PEEP were obtained during end-inspiratory and end-expiratory pauses at zero-flow points. Driving pressure was determined as the difference between plateau pressure and total PEEP, and respiratory system compliance was calculated as tidal volume divided by driving pressure. All patients were sedated and under neuromuscular blockade during measurements.</p><p id="Par14">For the first PP session, we selected the following four time points based on the protocol described in a previously published study by another group: (1) supine before PP (just before the patient was turned to the PP); (2) during PP (4&#x000a0;h within the first PP); (3) end PP (just before the patient was turned back to the supine position); and (4) supine after PP (4&#x000a0;h after resupination) [<xref ref-type="bibr" rid="CR22">22</xref>].</p><p id="Par15">At each time point, ventilatory variables, arterial blood gas, hemodynamic status, and EIT data were collected. Due to the limited feasibility of obtaining high-quality echocardiographic images while patients were in PP, transthoracic echocardiography was performed only in the supine position before and after PP.</p></sec><sec id="Sec5"><title>EIT data analysis</title><p id="Par16">EIT data were acquired using a standard device (PulmoVista<sup>&#x000ae;</sup>500; Dr&#x000e4;ger, L&#x000fc;beck, Germany) at a sampling rate of 20&#x000a0;Hz and stored for offline analysis. The EIT belt was positioned directly below the armpits, between the fourth and fifth intercostal spaces. The position of the EIT belt was marked with a pen to avoid belt displacement after turning patients prone. After a 5-minute baseline recording of EIT data, an end-expiratory breath hold lasting 10&#x000a0;s was performed. Two seconds into the occlusion, a 10 mL bolus of 5% NaCl solution was manually injected through the central venous catheter over less than 2&#x000a0;s. The saline bolus traversed the pulmonary circulation, producing an impedance dilution curve that exhibited typical first-pass kinetics [<xref ref-type="bibr" rid="CR23">23</xref>].</p><p id="Par17">EIT ventilation maps were analyzed offline by averaging the values of five consecutive respiratory cycles selected from a visually stable segment within the 1-minute recording prior to saline injection, after respiratory and hemodynamic stabilization. For the quantitative analysis of ventilation and perfusion distributions, the lungs were divided into four non-overlapping horizontal regions of interest (ROIs) from ventral to dorsal: ventral (ROI 1), medial-ventral (ROI 2), medial-dorsal (ROI 3), and dorsal (ROI 4). Each ROI had an identical vertical height corresponding to 25% of the anteroposterior diameter.</p><p id="Par18">The regional functional ventilation map was calculated by subtracting the end-expiratory impedance from the end-inspiratory impedance, representing the local volume variation during tidal breathing. From the ventilation map analysis, the following measures were assessed:</p><p id="Par19">
<list list-type="order"><list-item><p id="Par20">The percentage of ventilation distribution in each region was calculated.</p></list-item><list-item><p id="Par21">The global inhomogeneity (GI) index was used to evaluate ventilation distribution [<xref ref-type="bibr" rid="CR24">24</xref>].</p></list-item><list-item><p id="Par22">The center of ventilation (CoV) was calculated to describe the vertical (ventral-to-dorsal) distribution [<xref ref-type="bibr" rid="CR25">25</xref>].</p></list-item></list>
</p><p id="Par23">Regional functional perfusion maps were derived by analyzing the slope of the time-impedance curve after saline injection, after excluding the cardiac region from the images. Ventilated and perfused regions were defined as pixels exceeding 20% of maximum values in the functional ventilation and perfusion maps, respectively. From the perfusion map analysis, four measures were calculated:</p><p id="Par24">
<list list-type="order"><list-item><p id="Par25">The percentage of perfusion distribution in each ROI.</p></list-item><list-item><p id="Par26">Dead space (%): regions ventilated but not perfused.</p></list-item><list-item><p id="Par27">Shunt (%): regions perfused but not ventilated.</p></list-item><list-item><p id="Par28">V/Q matching (%): regions both ventilated and perfused.</p></list-item></list>
</p></sec><sec id="Sec6"><title>Prone positioning</title><p id="Par29">In our respiratory ICU, PP is routinely performed for ARDS patients with PaO<sub>2</sub>/FiO<sub>2</sub>&#x02009;&#x0003c;&#x02009;150&#x000a0;mm Hg, with the final decision left to the treating physicians. Patients began PP within 24&#x000a0;h of enrollment and were maintained in that position for 16 consecutive hours. The criteria for stopping PP were as follows: (1) PaO<sub>2</sub>/FiO<sub>2</sub>&#x02009;&#x02265;&#x02009;150&#x000a0;mm Hg in the supine position 4&#x000a0;h after the end of PP; (2) a decrease in PaO<sub>2</sub>/FiO<sub>2</sub>&#x02009;&#x0003e;&#x02009;20% after PP compared with the ratio in the supine position; or (3) any other life-threatening complication requiring discontinuation, as determined by the attending physician. We collected the duration and number of PP sessions, as well as complications associated with PP.</p></sec><sec id="Sec7"><title>Classifications</title><p id="Par30">Previous studies by other groups have shown that V/Q matching generally improves by about 10% in the early phase after PP [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR20">20</xref>]. Therefore, patients in this study were classified as responders or non-responders based on whether their V/Q matching improvement reached&#x02009;&#x02265;&#x02009;10% 4&#x000a0;h within the first PP (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>).</p><p id="Par31">
<fig id="Fig1"><label>Fig. 1</label><caption><p>Changes in V/Q matching, dead space, and shunt during the first PP session in two representative patients with moderate to severe ARDS. Each row corresponds to different time points: supine before PP, during PP, end PP, and supine after PP. Quantitative percentages for each parameter are provided to the right of the V/Q matching maps. <bold>(A)</bold> A responder exhibited a significant improvement in V/Q matching, increasing from 68.2% before PP to 82.6% within 4&#x000a0;h of the first PP session. This was accompanied by a moderate increase in dead space from 3.7&#x02013;12.8%, while shunt showed a substantial reduction, from 28.1&#x02013;4.6%. <bold>(B)</bold> A non-responder showed minimal improvement in V/Q matching, with an increase from 68.3% before PP to 71.6% within 4&#x000a0;h of the first PP session. Dead space increased slightly, from 14.4&#x02013;16.5%, while shunt decreased modestly, from 17.3&#x02013;11.9%. V/Q ventilation-perfusion, PP prone positioning, ARDS, acute respiratory distress syndrome</p></caption><graphic xlink:href="13613_2025_1489_Fig1_HTML" id="d33e444"/></fig>
</p></sec><sec id="Sec8"><title>Study endpoints</title><p id="Par32">The primary endpoint was ICU mortality, while the secondary endpoint was ventilator-free days at day 28. Other endpoints recorded for each group included 28-day mortality, length of ICU and hospital stay, oxygenation deterioration requiring VV-ECMO support, use of continuous renal replacement therapy (CRRT), and tracheostomy. Information on the causes of death, including the presence of therapeutic limitations, was also collected.</p></sec><sec id="Sec9"><title>Statistical analysis</title><p id="Par33">To calculate the study sample size, we assumed a 2:1 ratio between responders and non-responders. A total of 69 patients were required to detect a 20% difference in mortality between the two groups, with a power of 0.8 and an alpha level of 0.025. To account for potential dropouts, we included 77 patients in the study.</p><p id="Par34">Continuous variables are presented as means&#x02009;&#x000b1;&#x02009;standard deviation or medians with interquartile ranges. Comparisons between groups were performed using Student&#x02019;s t-test or the Mann-Whitney U test, as appropriate. Categorical variables were analyzed using the chi-square test or Fisher&#x02019;s exact test. Repeated measures analysis of variance (ANOVA) or the Friedman test, with post-hoc Bonferroni or Dunn&#x02019;s multiple comparisons, were used to analyze data obtained at each time point during PP, when applicable. Correlation between continuous variables was assessed using the Spearman regression coefficient. ICU mortality was compared using Kaplan-Meier survival estimates, and a log-rank test was applied to compare the two groups. Risk factors associated with ICU mortality were identified through univariate analysis. Variables with statistical significance (<italic>P</italic>&#x02009;&#x02264;&#x02009;0.1) in the univariate analysis were included in the multivariate analysis, which was conducted using multiple logistic regression with backward stepwise selection. No imputation for missing data was performed because all analyzed cases were complete.</p><p id="Par35">All <italic>P</italic> values were two-sided, and values less than 0.05 were considered significant. Data were analyzed using R version 4.3.1 (R Foundation for Statistical Computing, Vienna, Austria) and GraphPad Prism version 8 (GraphPad Software Inc., San Diego, CA, USA).</p></sec></sec><sec id="Sec10"><title>Results</title><sec id="Sec11"><title>Study population</title><p id="Par36">From April 2023 to October 2024, 77 patients were enrolled in the study, with 46 patients (59.7%) classified as responders and 31 patients (40.3%) as non-responders based on V/Q matching improvement of &#x02265;&#x02009;10% 4&#x000a0;h within the first PP session (Figure <xref rid="MOESM1" ref-type="media">S1</xref>). The main characteristics of the study population are summarized in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>. The mean age of patients was 61.5&#x02009;&#x000b1;&#x02009;13.9 years, and 50 patients (64.9%) were male. The primary cause of ARDS was pneumonia (58.4%), with no significant difference in etiology between the groups. The proportion of severe ARDS was slightly higher in responders than in non-responders, but the difference was not statistically significant (41.3% vs. 29.0%; <italic>P</italic>&#x02009;=&#x02009;0.272). The median duration of IMV before the first PP session was 7 (range, 5&#x02013;8) hours. Hemodynamic parameters, arterial blood gases, and ventilatory variables at enrollment showed no significant differences between the two groups.</p><p id="Par37">
<table-wrap id="Tab1"><label>Table 1</label><caption><p>Main characteristics of study population</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Characteristic</th><th align="left">All patients<break/>(<italic>n</italic>&#x02009;=&#x02009;77)</th><th align="left">Responders<break/>(<italic>n</italic>&#x02009;=&#x02009;46)</th><th align="left">Non-responders<break/>(<italic>n</italic>&#x02009;=&#x02009;31)</th><th align="left">
<italic>P</italic>
</th></tr></thead><tbody><tr><td align="left"><bold>Age</bold>,<bold> years</bold></td><td align="left">61.5&#x02009;&#x000b1;&#x02009;13.9</td><td align="left">60.4&#x02009;&#x000b1;&#x02009;15.1</td><td align="left">63.2&#x02009;&#x000b1;&#x02009;12.0</td><td char="." align="char">0.428</td></tr><tr><td align="left"><bold>Male</bold>,<bold> no. (%)</bold></td><td align="left">50 (64.9)</td><td align="left">30 (65.2)</td><td align="left">20 (64.5)</td><td char="." align="char">0.950</td></tr><tr><td align="left"><bold>Body mass index</bold>,<bold> kg/m</bold><sup><bold>2</bold></sup></td><td align="left">25.3 (23.4&#x02013;27.1)</td><td align="left">25.7 (23.5&#x02013;27.2)</td><td align="left">24.5 (23.2&#x02013;27.6)</td><td char="." align="char">0.464</td></tr><tr><td align="left">
<bold>APACHE II score at enrollment</bold>
</td><td align="left">17 (13&#x02013;22)</td><td align="left">17 (13&#x02013;23)</td><td align="left">17 (11&#x02013;22)</td><td char="." align="char">0.960</td></tr><tr><td align="left">
<bold>SOFA score at enrollment</bold>
</td><td align="left">10 (8&#x02013;12)</td><td align="left">9 (8&#x02013;11)</td><td align="left">11 (8&#x02013;12)</td><td char="." align="char">0.358</td></tr><tr><td align="left">
<bold>Murray score at enrollment</bold>
</td><td align="left">3.00 (2.75&#x02013;3.25)</td><td align="left">3.00 (3.00&#x02013;3.25)</td><td align="left">3.25 (2.50&#x02013;3.25)</td><td char="." align="char">0.877</td></tr><tr><td align="left"><bold>Cause of ARDS</bold>,<bold> no. (%)</bold></td><td align="left"/><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#x02003;Pneumonia</td><td align="left">45 (58.4)</td><td align="left">24 (52.2)</td><td align="left">21 (71.0)</td><td char="." align="char">0.174</td></tr><tr><td align="left">&#x02003;&#x02003;COVID-19 pneumonia</td><td align="left">15 (19.5)</td><td align="left">8 (17.4)</td><td align="left">7 (22.6)</td><td char="." align="char">0.573</td></tr><tr><td align="left">&#x02003;Aspiration</td><td align="left">10 (13.0)</td><td align="left">7 (15.2)</td><td align="left">3 (9.7)</td><td char="." align="char">0.716</td></tr><tr><td align="left">&#x02003;Non-pulmonary sepsis</td><td align="left">12 (15.6)</td><td align="left">9 (19.6)</td><td align="left">3 (9.7)</td><td char="." align="char">0.394</td></tr><tr><td align="left">&#x02003;Trauma</td><td align="left">7 (9.1)</td><td align="left">4 (8.7)</td><td align="left">3 (9.7)</td><td char="." align="char">1.000</td></tr><tr><td align="left">&#x02003;Acute pancreatitis</td><td align="left">3 (3.9)</td><td align="left">2 (4.3)</td><td align="left">1 (3.2)</td><td char="." align="char">1.000</td></tr><tr><td align="left"><bold>ARDS severity</bold>,<bold> no. (%)</bold></td><td align="left"/><td align="left"/><td align="left"/><td char="." align="char">0.272</td></tr><tr><td align="left">&#x02003;Moderate: PaO<sub>2</sub>:FiO<sub>2</sub> 100&#x02013;200 mmHg</td><td align="left">49 (63.6)</td><td align="left">27 (58.7)</td><td align="left">22 (71.0)</td><td align="left"/></tr><tr><td align="left">&#x02003;Severe: PaO<sub>2</sub>:FiO<sub>2</sub>&#x02009;&#x0003c;&#x02009;100 mmHg</td><td align="left">28 (36.4)</td><td align="left">19 (41.3)</td><td align="left">9 (29.0)</td><td align="left"/></tr><tr><td align="left"><bold>Comorbidity</bold>,<bold> no. (%)</bold></td><td align="left"/><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#x02003;Immunocompromised</td><td align="left">14 (18.2)</td><td align="left">10 (21.7)</td><td align="left">4 (12.9)</td><td char="." align="char">0.324</td></tr><tr><td align="left">&#x02003;COPD or asthma</td><td align="left">15 (19.5)</td><td align="left">10 (21.7)</td><td align="left">5 (16.1)</td><td char="." align="char">0.542</td></tr><tr><td align="left">&#x02003;Coronary artery disease</td><td align="left">8 (10.4)</td><td align="left">4 (8.7)</td><td align="left">4 (12.9)</td><td char="." align="char">0.707</td></tr><tr><td align="left">&#x02003;Hypertension</td><td align="left">32 (41.6)</td><td align="left">17 (37.0)</td><td align="left">15 (48.4)</td><td char="." align="char">0.318</td></tr><tr><td align="left">&#x02003;Diabetes mellitus</td><td align="left">9 (11.7)</td><td align="left">4 (8.7)</td><td align="left">5 (16.1)</td><td char="." align="char">0.526</td></tr><tr><td align="left">&#x02003;Chronic renal insufficiency</td><td align="left">10 (13.0)</td><td align="left">7 (15.2)</td><td align="left">3 (9.7)</td><td char="." align="char">0.716</td></tr><tr><td align="left"><bold>Duration of IMV before first PP</bold>,<bold> hours</bold></td><td align="left">7 (5&#x02013;8)</td><td align="left">6 (5&#x02013;8)</td><td align="left">7 (6&#x02013;8)</td><td char="." align="char">0.423</td></tr><tr><td align="left">
<bold>Hemodynamic status at enrollment</bold>
</td><td align="left"/><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#x02003;Norepinephrine dose, &#x000b5;g/kg/min</td><td align="left">0.00 (0.00&#x02013;0.30)</td><td align="left">0.00 (0.00&#x02013;0.30)</td><td align="left">0.00 (0.00&#x02013;0.35)</td><td char="." align="char">0.962</td></tr><tr><td align="left">&#x02003;Lactate, mmol/L</td><td align="left">1.7 (1.1&#x02013;2.1)</td><td align="left">1.7 (1.1&#x02013;1.9)</td><td align="left">1.7 (1.1&#x02013;2.4)</td><td char="." align="char">0.396</td></tr><tr><td align="left">&#x02003;Heart rate, beats/min</td><td align="left">87.9&#x02009;&#x000b1;&#x02009;21.2</td><td align="left">87.4&#x02009;&#x000b1;&#x02009;21.6</td><td align="left">86.6&#x02009;&#x000b1;&#x02009;21.1</td><td char="." align="char">0.817</td></tr><tr><td align="left">&#x02003;Mean arterial pressure, mmHg</td><td align="left">83.8&#x02009;&#x000b1;&#x02009;11.2</td><td align="left">84.8&#x02009;&#x000b1;&#x02009;11.8</td><td align="left">82.4&#x02009;&#x000b1;&#x02009;10.4</td><td char="." align="char">0.414</td></tr><tr><td align="left">&#x02003;CVP, mmHg</td><td align="left">10 (7&#x02013;13)</td><td align="left">10 (7&#x02013;13)</td><td align="left">10 (8&#x02013;14)</td><td char="." align="char">0.779</td></tr><tr><td align="left">&#x02003;ScvO<sub>2</sub>, %</td><td align="left">59.8&#x02009;&#x000b1;&#x02009;10.3</td><td align="left">58.7&#x02009;&#x000b1;&#x02009;10.6</td><td align="left">61.5&#x02009;&#x000b1;&#x02009;10.0</td><td char="." align="char">0.296</td></tr><tr><td align="left">
<bold>Arterial blood gas at enrollment</bold>
</td><td align="left"/><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#x02003;pH</td><td align="left">7.41 (7.35&#x02013;7.46)</td><td align="left">7.42 (7.35&#x02013;7.47)</td><td align="left">7.40 (7.34&#x02013;7.43)</td><td char="." align="char">0.211</td></tr><tr><td align="left">&#x02003;PaO<sub>2</sub>, mmHg</td><td align="left">69.4&#x02009;&#x000b1;&#x02009;10.9</td><td align="left">68.2&#x02009;&#x000b1;&#x02009;11.2</td><td align="left">71.2&#x02009;&#x000b1;&#x02009;10.5</td><td char="." align="char">0.297</td></tr><tr><td align="left">&#x02003;PaCO<sub>2</sub>, mmHg</td><td align="left">41.2&#x02009;&#x000b1;&#x02009;10.3</td><td align="left">40.9&#x02009;&#x000b1;&#x02009;10.6</td><td align="left">41.5&#x02009;&#x000b1;&#x02009;10.2</td><td char="." align="char">0.828</td></tr><tr><td align="left">&#x02003;HCO<sub>3</sub><sup>&#x02212;</sup>, mmol/L</td><td align="left">25.9&#x02009;&#x000b1;&#x02009;4.4</td><td align="left">26.0&#x02009;&#x000b1;&#x02009;3.5</td><td align="left">25.9&#x02009;&#x000b1;&#x02009;5.6</td><td char="." align="char">0.916</td></tr><tr><td align="left">&#x02003;PaO<sub>2</sub>:FiO<sub>2</sub> ratio, mmHg</td><td align="left">110.9&#x02009;&#x000b1;&#x02009;23.1</td><td align="left">108.7&#x02009;&#x000b1;&#x02009;24.9</td><td align="left">114.2&#x02009;&#x000b1;&#x02009;20.2</td><td char="." align="char">0.357</td></tr><tr><td align="left">
<bold>Ventilatory variables at enrollment</bold>
</td><td align="left"/><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#x02003;FiO<sub>2</sub></td><td align="left">0.60 (0.50&#x02013;0.80)</td><td align="left">0.60 (0.50&#x02013;0.80)</td><td align="left">0.60 (0.50&#x02013;0.75)</td><td char="." align="char">0.724</td></tr><tr><td align="left">&#x02003;PEEP, mmH<sub>2</sub>O</td><td align="left">10.4&#x02009;&#x000b1;&#x02009;1.9</td><td align="left">10.6&#x02009;&#x000b1;&#x02009;2.0</td><td align="left">10.1&#x02009;&#x000b1;&#x02009;1.8</td><td char="." align="char">0.306</td></tr><tr><td align="left">&#x02003;Tidal volume, ml</td><td align="left">415&#x02009;&#x000b1;&#x02009;51</td><td align="left">408&#x02009;&#x000b1;&#x02009;52</td><td align="left">425&#x02009;&#x000b1;&#x02009;50</td><td char="." align="char">0.201</td></tr><tr><td align="left">&#x02003;Tidal volume, ml/PBM</td><td align="left">6.5&#x02009;&#x000b1;&#x02009;0.7</td><td align="left">6.4&#x02009;&#x000b1;&#x02009;0.6</td><td align="left">6.5&#x02009;&#x000b1;&#x02009;0.9</td><td char="." align="char">0.623</td></tr><tr><td align="left">&#x02003;Respiratory rate, breaths/min</td><td align="left">23.9&#x02009;&#x000b1;&#x02009;3.0</td><td align="left">24.1&#x02009;&#x000b1;&#x02009;3.2</td><td align="left">23.5&#x02009;&#x000b1;&#x02009;2.7</td><td char="." align="char">0.430</td></tr><tr><td align="left">&#x02003;Peak airway pressure, cmH<sub>2</sub>O</td><td align="left">27.1&#x02009;&#x000b1;&#x02009;4.5</td><td align="left">27.7&#x02009;&#x000b1;&#x02009;5.0</td><td align="left">26.1&#x02009;&#x000b1;&#x02009;3.5</td><td char="." align="char">0.156</td></tr><tr><td align="left">&#x02003;Plateau pressure, cmH<sub>2</sub>O</td><td align="left">22.8&#x02009;&#x000b1;&#x02009;4.0</td><td align="left">23.2&#x02009;&#x000b1;&#x02009;4.1</td><td align="left">22.2&#x02009;&#x000b1;&#x02009;3.8</td><td char="." align="char">0.296</td></tr><tr><td align="left">&#x02003;Driving pressure, cmH<sub>2</sub>O</td><td align="left">12.4&#x02009;&#x000b1;&#x02009;3.2</td><td align="left">12.7&#x02009;&#x000b1;&#x02009;3.3</td><td align="left">12.1&#x02009;&#x000b1;&#x02009;3.1</td><td char="." align="char">0.499</td></tr><tr><td align="left">&#x02003;Compliance, ml/cmH<sub>2</sub>O</td><td align="left">35.2&#x02009;&#x000b1;&#x02009;8.0</td><td align="left">34.1&#x02009;&#x000b1;&#x02009;8.5</td><td align="left">36.8&#x02009;&#x000b1;&#x02009;7.0</td><td char="." align="char">0.197</td></tr></tbody></table><table-wrap-foot><p>APACHE II Acute Physiology and Chronic Health Evaluation II, ICU intensive care unit, SOFA sequential organ failure assessment, ARDS acute respiratory distress syndrome, COVID-19 coronavirus disease 2019, PaO<sub>2</sub>:FiO<sub>2</sub> ratio of the partial pressure of arterial oxygen to the fraction of inspired oxygen, COPD chronic obstructive pulmonary disease, IMV invasive mechanical ventilation, PP prone positioning, CVP central venous pressure, ScvO<sub>2</sub> central venous oxygen saturation, PaO<sub>2</sub> partial pressure of arterial oxygen, PaCO<sub>2</sub> partial pressure of arterial carbon dioxide, HCO<sub>3</sub><sup>&#x02212;</sup> bicarbonate, PEEP positive end-expiratory pressure, PBM predicted body weight</p></table-wrap-foot></table-wrap>
</p></sec><sec id="Sec12"><title>Change in ventilatory variables, arterial blood gases, and hemodynamic status</title><p id="Par38">FiO<sub>2</sub> was significantly reduced during PP (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001). Plateau pressure and driving pressure progressively decreased (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001), while compliance significantly improved during PP and remained elevated in the supine position after PP (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001) (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>). PEEP, tidal volume, driving pressure, and compliance showed no significant differences between responders and non-responders at the four identified time points during the first PP session (Table <xref rid="MOESM1" ref-type="media">S1</xref> and Figure <xref rid="MOESM2" ref-type="media">S2</xref>).</p><p id="Par39">
<table-wrap id="Tab2"><label>Table 2</label><caption><p>Ventilatory variables, arterial blood gas, hemodynamic status, and electrical impedance tomography data at four identified time points throughout the first PP session</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Variables</th><th align="left">Supine before PP<break/>(<italic>n</italic>&#x02009;=&#x02009;77)</th><th align="left">During PP<break/>(<italic>n</italic>&#x02009;=&#x02009;77)</th><th align="left">End PP<break/>(<italic>n</italic>&#x02009;=&#x02009;77)</th><th align="left">Supine after PP<break/>(<italic>n</italic>&#x02009;=&#x02009;77)</th><th align="left">
<italic>P</italic>
</th></tr></thead><tbody><tr><td align="left">
<bold>Ventilatory variables</bold>
</td><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#x02003;FiO<sub>2</sub></td><td align="left">0.60 (0.50&#x02013;0.70)</td><td align="left">0.50 (0.40&#x02013;0.55)*</td><td align="left">0.50 (0.40&#x02013;0.55)*</td><td align="left">0.50 (0.40&#x02013;0.55)*</td><td char="." align="char">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">&#x02003;PEEP, mmH<sub>2</sub>O</td><td align="left">10.6&#x02009;&#x000b1;&#x02009;1.9</td><td align="left">10.5&#x02009;&#x000b1;&#x02009;2.1</td><td align="left">10.4&#x02009;&#x000b1;&#x02009;2.0</td><td align="left">10.6&#x02009;&#x000b1;&#x02009;1.8</td><td char="." align="char">0.331</td></tr><tr><td align="left">&#x02003;Tidal volume, ml</td><td align="left">416&#x02009;&#x000b1;&#x02009;53</td><td align="left">410&#x02009;&#x000b1;&#x02009;57</td><td align="left">414&#x02009;&#x000b1;&#x02009;55</td><td align="left">413&#x02009;&#x000b1;&#x02009;52</td><td char="." align="char">0.771</td></tr><tr><td align="left">&#x02003;Tidal volume, ml/PBM</td><td align="left">6.5&#x02009;&#x000b1;&#x02009;0.8</td><td align="left">6.3&#x02009;&#x000b1;&#x02009;0.8</td><td align="left">6.4&#x02009;&#x000b1;&#x02009;0.8</td><td align="left">6.4&#x02009;&#x000b1;&#x02009;0.8</td><td char="." align="char">0.800</td></tr><tr><td align="left">&#x02003;Respiratory rate, breaths/min</td><td align="left">23.6&#x02009;&#x000b1;&#x02009;3.3</td><td align="left">23.0&#x02009;&#x000b1;&#x02009;4.0</td><td align="left">22.4&#x02009;&#x000b1;&#x02009;3.5</td><td align="left">23.2&#x02009;&#x000b1;&#x02009;3.6</td><td char="." align="char">0.174</td></tr><tr><td align="left">&#x02003;Peak airway pressure, cmH<sub>2</sub>O</td><td align="left">27.2&#x02009;&#x000b1;&#x02009;5.0</td><td align="left">27.2&#x02009;&#x000b1;&#x02009;4.8</td><td align="left">26.6&#x02009;&#x000b1;&#x02009;4.7<sup>#</sup></td><td align="left">26.5&#x02009;&#x000b1;&#x02009;4.5<sup>#</sup></td><td char="." align="char">0.010</td></tr><tr><td align="left">&#x02003;Plateau pressure, cmH<sub>2</sub>O</td><td align="left">23.1&#x02009;&#x000b1;&#x02009;4.3</td><td align="left">22.5&#x02009;&#x000b1;&#x02009;4.2<sup>#</sup></td><td align="left">21.9&#x02009;&#x000b1;&#x02009;3.8*</td><td align="left">22.3&#x02009;&#x000b1;&#x02009;4.0*</td><td char="." align="char">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">&#x02003;Driving pressure, cmH<sub>2</sub>O</td><td align="left">12.5&#x02009;&#x000b1;&#x02009;3.5</td><td align="left">12.0&#x02009;&#x000b1;&#x02009;3.5<sup>#</sup></td><td align="left">11.4&#x02009;&#x000b1;&#x02009;3.2*</td><td align="left">11.7&#x02009;&#x000b1;&#x02009;3.3*</td><td char="." align="char">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">&#x02003;Compliance, ml/cmH<sub>2</sub>O</td><td align="left">35.4&#x02009;&#x000b1;&#x02009;8.6</td><td align="left">36.3&#x02009;&#x000b1;&#x02009;8.4<sup>#</sup></td><td align="left">38.1&#x02009;&#x000b1;&#x02009;8.9*</td><td align="left">37.2&#x02009;&#x000b1;&#x02009;8.6*</td><td char="." align="char">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">
<bold>Arterial blood gas</bold>
</td><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#x02003;pH</td><td align="left">7.42 (7.37&#x02013;7.45)</td><td align="left">7.43 (7.38&#x02013;7.47)<sup>#</sup></td><td align="left">7.43 (7.39&#x02013;7.47)<sup>#</sup></td><td align="left">7.42 (7.37&#x02013;7.45)</td><td char="." align="char">0.001</td></tr><tr><td align="left">&#x02003;PaO<sub>2</sub>, mmHg</td><td align="left">69.1&#x02009;&#x000b1;&#x02009;11.7</td><td align="left">78.0&#x02009;&#x000b1;&#x02009;9.8*</td><td align="left">83.5&#x02009;&#x000b1;&#x02009;10.6*</td><td align="left">79.2&#x02009;&#x000b1;&#x02009;7.9*</td><td char="." align="char">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">&#x02003;PaCO<sub>2</sub>, mmHg</td><td align="left">41.8&#x02009;&#x000b1;&#x02009;9.7</td><td align="left">40.4&#x02009;&#x000b1;&#x02009;10.0*</td><td align="left">39.6&#x02009;&#x000b1;&#x02009;9.9*</td><td align="left">40.5&#x02009;&#x000b1;&#x02009;10.0*</td><td char="." align="char">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">&#x02003;HCO<sub>3</sub><sup>&#x02212;</sup>, mmol/L</td><td align="left">25.9&#x02009;&#x000b1;&#x02009;4.4</td><td align="left">26.0&#x02009;&#x000b1;&#x02009;3.9</td><td align="left">25.6&#x02009;&#x000b1;&#x02009;3.8</td><td align="left">26.0&#x02009;&#x000b1;&#x02009;3.4</td><td char="." align="char">0.621</td></tr><tr><td align="left">&#x02003;PaO<sub>2</sub>:FiO<sub>2</sub> ratio, mmHg</td><td align="left">113.2&#x02009;&#x000b1;&#x02009;24.9</td><td align="left">162.0&#x02009;&#x000b1;&#x02009;27.1*</td><td align="left">178.4&#x02009;&#x000b1;&#x02009;36.8*</td><td align="left">162.8&#x02009;&#x000b1;&#x02009;31.3*</td><td char="." align="char">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">&#x02003;Ventilatory ratio</td><td align="left">1.59 (1.33&#x02013;1.88)</td><td align="left">1.48 (1.26&#x02013;1.94)*</td><td align="left">1.42 (1.16&#x02013;1.80)*</td><td align="left">1.50 (1.24&#x02013;1.87)<sup>#</sup></td><td char="." align="char">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">
<bold>Hemodynamic status</bold>
</td><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#x02003;Norepinephrine dose, &#x000b5;g/kg/min</td><td align="left">0.00 (0.00&#x02013;0.30)</td><td align="left">0.05 (0.00&#x02013;0.30)</td><td align="left">0.05 (0.05&#x02013;0.30)</td><td align="left">0.05 (0.00&#x02013;0.30)</td><td char="." align="char">0.219</td></tr><tr><td align="left">&#x02003;Lactate, mmol/L</td><td align="left">1.5 (0.9&#x02013;2.2)</td><td align="left">1.4 (1.0&#x02013;1.9)</td><td align="left">1.4 (0.9&#x02013;2.2)</td><td align="left">1.3 (1.0&#x02013;1.9)</td><td char="." align="char">0.412</td></tr><tr><td align="left">&#x02003;Heart rate, beats/min</td><td align="left">92.1&#x02009;&#x000b1;&#x02009;17.6</td><td align="left">93.3&#x02009;&#x000b1;&#x02009;20.3</td><td align="left">91.4&#x02009;&#x000b1;&#x02009;17.5</td><td align="left">88.3&#x02009;&#x000b1;&#x02009;17.5</td><td char="." align="char">0.072</td></tr><tr><td align="left">&#x02003;Mean arterial pressure, mmHg</td><td align="left">81.4&#x02009;&#x000b1;&#x02009;12.9</td><td align="left">80.6&#x02009;&#x000b1;&#x02009;12.4</td><td align="left">80.3&#x02009;&#x000b1;&#x02009;10.9</td><td align="left">83.7&#x02009;&#x000b1;&#x02009;9.9</td><td char="." align="char">0.193</td></tr><tr><td align="left">&#x02003;CVP, mmHg</td><td align="left">10 (7&#x02013;13)</td><td align="left">12 (10&#x02013;14)<sup>#</sup></td><td align="left">13 (10&#x02013;14)*</td><td align="left">11 (8&#x02013;12)</td><td char="." align="char">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">&#x02003;ScvO<sub>2</sub>, %</td><td align="left">59.5&#x02009;&#x000b1;&#x02009;11.4</td><td align="left">67.3&#x02009;&#x000b1;&#x02009;9.6*</td><td align="left">71.6&#x02009;&#x000b1;&#x02009;11.3*</td><td align="left">67.3&#x02009;&#x000b1;&#x02009;8.0*</td><td char="." align="char">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">
<bold>Electrical impedance tomography</bold>
</td><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#x02003;Ventilation distribution, ventral, %</td><td align="left">63.0&#x02009;&#x000b1;&#x02009;14.9</td><td align="left">45.5&#x02009;&#x000b1;&#x02009;15.1*</td><td align="left">41.5&#x02009;&#x000b1;&#x02009;13.8*</td><td align="left">53.5&#x02009;&#x000b1;&#x02009;13.3*</td><td char="." align="char">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">&#x02003;Ventilation distribution, dorsal, %</td><td align="left">37.0&#x02009;&#x000b1;&#x02009;14.9</td><td align="left">54.5&#x02009;&#x000b1;&#x02009;15.1*</td><td align="left">58.5&#x02009;&#x000b1;&#x02009;13.8*</td><td align="left">46.5&#x02009;&#x000b1;&#x02009;13.3*</td><td char="." align="char">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">&#x02003;Ventilation distribution, ROI 1, %</td><td align="left">12.0 (8.0&#x02013;19.5)</td><td align="left">7.0 (4.6&#x02013;12.1)*</td><td align="left">8.0 (5.3&#x02013;10.4)*</td><td align="left">9.6 (5.4&#x02013;14.1)*</td><td char="." align="char">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">&#x02003;Ventilation distribution, ROI 2, %</td><td align="left">49.0&#x02009;&#x000b1;&#x02009;11.8</td><td align="left">36.7&#x02009;&#x000b1;&#x02009;11.4*</td><td align="left">33.5&#x02009;&#x000b1;&#x02009;10.4*</td><td align="left">42.6&#x02009;&#x000b1;&#x02009;9.5*</td><td char="." align="char">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">&#x02003;Ventilation distribution, ROI 3, %</td><td align="left">30.6&#x02009;&#x000b1;&#x02009;13.1</td><td align="left">44.6&#x02009;&#x000b1;&#x02009;12.2*</td><td align="left">47.1&#x02009;&#x000b1;&#x02009;10.0*</td><td align="left">37.9&#x02009;&#x000b1;&#x02009;13.4*</td><td char="." align="char">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">&#x02003;Ventilation distribution, ROI 4, %</td><td align="left">5.7 (3.8&#x02013;8.4)</td><td align="left">7.4 (5.0&#x02013;13.9)<sup>#</sup></td><td align="left">9.4 (6.3&#x02013;13.2)*</td><td align="left">8.0 (3.9&#x02013;12.7)</td><td char="." align="char">0.002</td></tr><tr><td align="left">&#x02003;GI index ventilation</td><td align="left">0.59 (0.56&#x02013;0.64)</td><td align="left">0.52 (0.50&#x02013;0.54)*</td><td align="left">0.50 (0.47&#x02013;0.52)*</td><td align="left">0.52 (0.49&#x02013;0.54)*</td><td char="." align="char">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">&#x02003;Center of ventilation, %</td><td align="left">44.19&#x02009;&#x000b1;&#x02009;5.77</td><td align="left">51.24&#x02009;&#x000b1;&#x02009;5.38*</td><td align="left">52.59&#x02009;&#x000b1;&#x02009;8.41*</td><td align="left">47.80&#x02009;&#x000b1;&#x02009;5.92*</td><td char="." align="char">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">&#x02003;Perfusion distribution, ventral, %</td><td align="left">58.8&#x02009;&#x000b1;&#x02009;11.3</td><td align="left">42.6&#x02009;&#x000b1;&#x02009;9.1*</td><td align="left">41.1&#x02009;&#x000b1;&#x02009;9.2*</td><td align="left">50.4&#x02009;&#x000b1;&#x02009;4.3*</td><td char="." align="char">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">&#x02003;Perfusion distribution, dorsal, %</td><td align="left">41.2&#x02009;&#x000b1;&#x02009;11.3</td><td align="left">57.4&#x02009;&#x000b1;&#x02009;9.1*</td><td align="left">58.9&#x02009;&#x000b1;&#x02009;9.2*</td><td align="left">49.6&#x02009;&#x000b1;&#x02009;4.3*</td><td char="." align="char">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">&#x02003;Perfusion distribution, ROI 1, %</td><td align="left">15.6&#x02009;&#x000b1;&#x02009;6.5</td><td align="left">9.1&#x02009;&#x000b1;&#x02009;3.8*</td><td align="left">9.0&#x02009;&#x000b1;&#x02009;4.4*</td><td align="left">13.4&#x02009;&#x000b1;&#x02009;2.6<sup>#</sup></td><td char="." align="char">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">&#x02003;Perfusion distribution, ROI 2, %</td><td align="left">43.3&#x02009;&#x000b1;&#x02009;9.0</td><td align="left">33.5&#x02009;&#x000b1;&#x02009;7.7*</td><td align="left">32.1&#x02009;&#x000b1;&#x02009;7.5*</td><td align="left">37.0&#x02009;&#x000b1;&#x02009;3.5*</td><td char="." align="char">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">&#x02003;Perfusion distribution, ROI 3, %</td><td align="left">31.5&#x02009;&#x000b1;&#x02009;9.3</td><td align="left">43.7&#x02009;&#x000b1;&#x02009;8.7*</td><td align="left">44.7&#x02009;&#x000b1;&#x02009;8.2*</td><td align="left">39.0&#x02009;&#x000b1;&#x02009;3.2*</td><td char="." align="char">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">&#x02003;Perfusion distribution, ROI 4, %</td><td align="left">7.5 (4.9&#x02013;12.5)</td><td align="left">12.8 (7.5&#x02013;20.4)<sup>#</sup></td><td align="left">13.2 (8.4&#x02013;19.1)*</td><td align="left">10.5 (6.9&#x02013;13.3)</td><td char="." align="char">0.003</td></tr><tr><td align="left">&#x02003;Shunt, %</td><td align="left">22.1&#x02009;&#x000b1;&#x02009;9.6</td><td align="left">17.8&#x02009;&#x000b1;&#x02009;9.8*</td><td align="left">17.2&#x02009;&#x000b1;&#x02009;10.1*</td><td align="left">19.1&#x02009;&#x000b1;&#x02009;11.3</td><td char="." align="char">0.008</td></tr><tr><td align="left">&#x02003;Shunt, ventral, %</td><td align="left">6.9&#x02009;&#x000b1;&#x02009;3.0</td><td align="left">6.7&#x02009;&#x000b1;&#x02009;3.6</td><td align="left">6.8&#x02009;&#x000b1;&#x02009;3.8</td><td align="left">6.5&#x02009;&#x000b1;&#x02009;3.9</td><td char="." align="char">0.901</td></tr><tr><td align="left">&#x02003;Shunt, dorsal, %</td><td align="left">15.2&#x02009;&#x000b1;&#x02009;6.6</td><td align="left">11.0&#x02009;&#x000b1;&#x02009;6.3*</td><td align="left">10.4&#x02009;&#x000b1;&#x02009;6.4*</td><td align="left">12.6&#x02009;&#x000b1;&#x02009;7.5<sup>#</sup></td><td char="." align="char">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">&#x02003;Dead space, %</td><td align="left">23.1&#x02009;&#x000b1;&#x02009;10.7</td><td align="left">15.4&#x02009;&#x000b1;&#x02009;7.2*</td><td align="left">13.5&#x02009;&#x000b1;&#x02009;8.9*</td><td align="left">19.1&#x02009;&#x000b1;&#x02009;12.2<sup>#</sup></td><td char="." align="char">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">&#x02003;Dead space, ventral, %</td><td align="left">17.3&#x02009;&#x000b1;&#x02009;8.1</td><td align="left">10.1&#x02009;&#x000b1;&#x02009;4.7*</td><td align="left">8.7&#x02009;&#x000b1;&#x02009;5.9*</td><td align="left">14.0&#x02009;&#x000b1;&#x02009;9.1<sup>#</sup></td><td char="." align="char">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">&#x02003;Dead space, dorsal, %</td><td align="left">5.7&#x02009;&#x000b1;&#x02009;2.7</td><td align="left">5.2&#x02009;&#x000b1;&#x02009;2.6</td><td align="left">4.8&#x02009;&#x000b1;&#x02009;3.1<sup>#</sup></td><td align="left">5.1&#x02009;&#x000b1;&#x02009;3.3</td><td char="." align="char">0.208</td></tr><tr><td align="left">&#x02003;V/Q matching, %</td><td align="left">59.0&#x02009;&#x000b1;&#x02009;8.6</td><td align="left">71.2&#x02009;&#x000b1;&#x02009;7.8*</td><td align="left">71.6&#x02009;&#x000b1;&#x02009;10.9*</td><td align="left">61.8&#x02009;&#x000b1;&#x02009;12.9</td><td char="." align="char">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">&#x02003;V/Q matching, ventral, %</td><td align="left">33.9&#x02009;&#x000b1;&#x02009;5.3</td><td align="left">38.0&#x02009;&#x000b1;&#x02009;4.5*</td><td align="left">35.7&#x02009;&#x000b1;&#x02009;5.6<sup>#</sup></td><td align="left">34.1&#x02009;&#x000b1;&#x02009;7.1</td><td char="." align="char">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">&#x02003;V/Q matching, dorsal, %</td><td align="left">25.1&#x02009;&#x000b1;&#x02009;3.9</td><td align="left">33.2&#x02009;&#x000b1;&#x02009;4.4*</td><td align="left">35.8&#x02009;&#x000b1;&#x02009;6.0*</td><td align="left">27.7&#x02009;&#x000b1;&#x02009;6.3*</td><td char="." align="char">&#x0003c;&#x02009;0.001</td></tr></tbody></table><table-wrap-foot><p>PP prone positioning, FiO<sub>2</sub> the fraction of inspired oxygen, PEEP positive end-expiratory pressure, PBM predicted body weight, PaO<sub>2</sub> partial pressure of arterial oxygen, PaCO<sub>2</sub> partial pressure of arterial carbon dioxide, HCO<sub>3</sub><sup>&#x02212;</sup> bicarbonate, CVP central venous pressure, ScvO<sub>2</sub> central venous oxygen saturation, ROI region of interest, GI, global inhomogeneity, V/Q ventilation/perfusion</p><p><italic>P</italic> value by one-way analysis of variance (ANOVA) for repeated measures</p><p><sup>#</sup><italic>P&#x02009;&#x0003c;</italic>&#x02009;0.05, * <italic>P&#x02009;&#x0003c;</italic>&#x02009;0.01 compare with before PP</p></table-wrap-foot></table-wrap>
</p><p id="Par40">Arterial blood gas analysis showed significant increases in PaO<sub>2</sub> and PaO<sub>2</sub>/FiO<sub>2</sub> during PP, with sustained improvement after PP (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001). Partial pressure of arterial carbon dioxide (PaCO<sub>2</sub>) levels decreased significantly during PP and remained lower in the supine position after PP (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001) (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>). Responders demonstrated significantly higher PaO<sub>2</sub>/FiO<sub>2</sub> than non-responders during PP, at the end of PP, and in the supine position after PP (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001) (Table <xref rid="MOESM1" ref-type="media">S1</xref> and Figure <xref rid="MOESM1" ref-type="media">S3</xref>).</p><p id="Par41">Hemodynamic parameters were stable throughout the first PP session. No significant changes were noted in norepinephrine doses, lactate levels, or mean arterial pressure across the four time points. Heart rate exhibited a slight but non-significant decrease from the supine position before PP to the supine after PP (<italic>P</italic>&#x02009;=&#x02009;0.072). Both central venous pressure (CVP) and central venous oxygen saturation (ScvO<sub>2</sub>) increased significantly during PP, with ScvO<sub>2</sub> remaining elevated even after resupination (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001) (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>, Table <xref rid="MOESM1" ref-type="media">S1</xref>, and Figure <xref rid="MOESM1" ref-type="media">S4</xref>).</p></sec><sec id="Sec13"><title>Change in ventilation, perfusion, and V/Q matching</title><p id="Par42">EIT data revealed a redistribution of ventilation and perfusion from ventral to dorsal regions during PP (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001) (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>; Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>, and Figure <xref rid="MOESM1" ref-type="media">S5</xref>).</p><p id="Par43">
<fig id="Fig2"><label>Fig. 2</label><caption><p>Changes in ventilation <bold>(A)</bold> and perfusion <bold>(B)</bold> distribution across four ventral-to-dorsal horizontal regions during the first PP session. PP prone positioning</p></caption><graphic xlink:href="13613_2025_1489_Fig2_HTML" id="d33e2030"/></fig>
</p><p id="Par44">The GI index decreased significantly during PP (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001), and this reduction was sustained in the supine position after PP. The CoV shifted significantly toward the dorsal regions during PP (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001), with this shift partially persisting in the supine position after PP. The GI index was significantly lower in responders than in non-responders (<italic>P</italic>&#x02009;=&#x02009;0.018), while the CoV was significantly higher in responders than in non-responders (<italic>P</italic>&#x02009;=&#x02009;0.006) during PP (Table <xref rid="MOESM1" ref-type="media">S1</xref> and Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>).</p><p id="Par45">
<fig id="Fig3"><label>Fig. 3</label><caption><p>Comparison of global inhomogeneity index <bold>(A)</bold> and center of ventilation <bold>(B)</bold> between responders and non-responders during the first PP session. PP prone positioning</p></caption><graphic xlink:href="13613_2025_1489_Fig3_HTML" id="d33e2068"/></fig>
</p><p id="Par46">Shunt decreased significantly during PP (<italic>P</italic>&#x02009;=&#x02009;0.008), with the reduction predominantly in the dorsal region (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001). Similarly, dead space decreased significantly (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001), primarily in the ventral region (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001). V/Q matching improved significantly in the first 4&#x000a0;h of PP, increasing from 59.0&#x02009;&#x000b1;&#x02009;8.6% before PP to 71.2&#x02009;&#x000b1;&#x02009;7.8% (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001). However, no further significant improvement was observed by the end of PP, and improvement was partially sustained in the supine position after PP (59.0&#x02009;&#x000b1;&#x02009;8.6% vs. 61.8&#x02009;&#x000b1;&#x02009;12.9%; <italic>P</italic>&#x02009;=&#x02009;0.084) (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>). Responders showed significantly lower shunt than non-responders during PP (<italic>P</italic>&#x02009;=&#x02009;0.019) and at the end of PP (<italic>P</italic>&#x02009;=&#x02009;0.015). V/Q matching was significantly higher in responders during PP (<italic>P</italic>&#x02009;=&#x02009;0.017), at the end of PP (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001), and in the supine position after PP (<italic>P</italic>&#x02009;=&#x02009;0.040). Furthermore, the improvement in V/Q matching in responders was significantly superior to that of non-responders 4&#x000a0;h within the first PP (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001) (Table <xref rid="MOESM1" ref-type="media">S1</xref> and Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>).</p><p id="Par47">
<fig id="Fig4"><label>Fig. 4</label><caption><p>Comparison of shunt <bold>(A)</bold>, dead space <bold>(B)</bold>, V/Q matching <bold>(C)</bold>, and their respective changes 4&#x000a0;h after the initiation of PP <bold>(D)</bold> between responders and non-responders during the first PP session. V/Q ventilation-perfusion, PP prone positioning</p></caption><graphic xlink:href="13613_2025_1489_Fig4_HTML" id="d33e2140"/></fig>
</p><p id="Par48">V/Q matching at 4&#x000a0;h within the first PP session was positively correlated with PaO<sub>2</sub>/FiO<sub>2</sub> (&#x003c1;&#x02009;=&#x02009;0.424, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001) and respiratory system compliance (&#x003c1;&#x02009;=&#x02009;0.413, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001). At the end of PP session, V/Q matching remained moderately associated with PaO<sub>2</sub>/FiO<sub>2</sub> (&#x003c1;&#x02009;=&#x02009;0.303, <italic>P</italic>&#x02009;=&#x02009;0.007) and respiratory system compliance (&#x003c1;&#x02009;=&#x02009;0.262, <italic>P</italic>&#x02009;=&#x02009;0.021) (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>).</p><p id="Par49">
<fig id="Fig5"><label>Fig. 5</label><caption><p>Relationship between V/Q matching and PaO<sub>2</sub>/FiO<sub>2</sub> at 4&#x000a0;h within the first PP session <bold>(A)</bold>, V/Q matching and respiratory system compliance at 4&#x000a0;h within the first PP session <bold>(B)</bold>, V/Q matching and PaO<sub>2</sub>/FiO<sub>2</sub> at the end of PP session <bold>(C)</bold>, and V/Q matching and respiratory system compliance at the end of PP session <bold>(D)</bold> V/Q ventilation-perfusion, PaO<sub>2</sub>/FiO<sub>2</sub> ratio of the partial pressure of arterial oxygen to the fraction of inspired oxygen, PP prone positioning</p></caption><graphic xlink:href="13613_2025_1489_Fig6_HTML" id="d33e2202"/></fig>
</p></sec><sec id="Sec14"><title>Clinical outcomes, PP-related complications, and cause of death</title><p id="Par50">Clinical outcomes, PP-related complications, and cause of death are shown in Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>. ICU mortality and 28-day mortality was significantly lower in responders than in non-responders (28.3% vs. 51.6%; <italic>P</italic>&#x02009;=&#x02009;0.038). Kaplan-Meier analysis from study enrollment to day 28 further demonstrated that responders had a significantly lower ICU mortality than non-responders (<italic>P</italic>&#x02009;=&#x02009;0.032) (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>). Ventilator-free days at day 28 were significantly higher in responders than in non-responders (16 [range, 0&#x02013;21] days vs. 9 [range, 0&#x02013;15] days; <italic>P</italic>&#x02009;=&#x02009;0.024). Notably, three non-responders required VV-ECMO support due to oxygenation deterioration. There were no significant differences in ICU or hospital length of stay, CRRT, or tracheostomy between the groups.</p><p id="Par51">
<table-wrap id="Tab3"><label>Table 3</label><caption><p>Clinical outcomes, PP-related complications, and cause of death</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Outcome</th><th align="left">All patients<break/>(<italic>n</italic>&#x02009;=&#x02009;77)</th><th align="left">Responders<break/>(<italic>n</italic>&#x02009;=&#x02009;46)</th><th align="left">Non-responders<break/>(<italic>n</italic>&#x02009;=&#x02009;31)</th><th align="left">
<italic>P</italic>
</th></tr></thead><tbody><tr><td align="left">
<bold>Primary end point</bold>
</td><td align="left"/><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#x02003;ICU mortality no. (%)</td><td align="left">29 (37.7)</td><td align="left">13 (28.3)</td><td align="left">16 (51.6)</td><td char="." align="char">0.038</td></tr><tr><td align="left">
<bold>Secondary end point</bold>
</td><td align="left"/><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#x02003;Ventilator-free days at day 28, days</td><td align="left">13 (0&#x02013;18)</td><td align="left">16 (0&#x02013;21)</td><td align="left">9 (0&#x02013;15)</td><td char="." align="char">0.024</td></tr><tr><td align="left">
<bold>Other end points</bold>
</td><td align="left"/><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#x02003;28-day mortality, no. (%)</td><td align="left">29 (37.7)</td><td align="left">13 (28.3)</td><td align="left">16 (51.6)</td><td char="." align="char">0.038</td></tr><tr><td align="left">&#x02003;ICU length of stay, days</td><td align="left">18 (10&#x02013;26)</td><td align="left">18 (11&#x02013;25)</td><td align="left">19 (10&#x02013;27)</td><td char="." align="char">0.615</td></tr><tr><td align="left">&#x02003;Hospital length of stay, days</td><td align="left">24 (14&#x02013;33)</td><td align="left">24 (16&#x02013;32)</td><td align="left">21 (13&#x02013;35)</td><td char="." align="char">0.656</td></tr><tr><td align="left">&#x02003;Veno-venous ECMO, no. (%)</td><td align="left">4 (5.2)</td><td align="left">0 (0.0)</td><td align="left">3 (9.7)</td><td char="." align="char">0.061</td></tr><tr><td align="left">&#x02003;CRRT, no. (%)</td><td align="left">17 (22.1)</td><td align="left">11 (23.9)</td><td align="left">6 (19.4)</td><td char="." align="char">0.636</td></tr><tr><td align="left">&#x02003;Tracheostomy, no. (%)</td><td align="left">23 (29.9)</td><td align="left">13 (28.3)</td><td align="left">10 (32.3)</td><td char="." align="char">0.707</td></tr><tr><td align="left">
<bold>Prone positioning</bold>
</td><td align="left"/><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#x02003;Duration of first PP, hours</td><td align="left">16 (15&#x02013;16)</td><td align="left">16 (14&#x02013;16)</td><td align="left">16 (15&#x02013;16)</td><td char="." align="char">0.196</td></tr><tr><td align="left">&#x02003;Number of PP sessions</td><td align="left">3 (2&#x02013;5)</td><td align="left">3 (3&#x02013;5)</td><td align="left">3 (2&#x02013;5)</td><td char="." align="char">0.339</td></tr><tr><td align="left">&#x02003;Major complications no. (%)</td><td align="left"/><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#x02003;&#x02003;Accidental extubation</td><td align="left">1 (1.3)</td><td align="left">1 (2.2)</td><td align="left">0 (0.0)</td><td char="." align="char">1.000</td></tr><tr><td align="left">&#x02003;&#x02003;Airway dislodgement</td><td align="left">5 (6.5)</td><td align="left">3 (6.5)</td><td align="left">2 (6.5)</td><td char="." align="char">1.000</td></tr><tr><td align="left">&#x02003;&#x02003;Endotracheal tube obstruction</td><td align="left">5 (6.5)</td><td align="left">2 (4.3)</td><td align="left">3 (9.7)</td><td char="." align="char">0.387</td></tr><tr><td align="left">&#x02003;Minor complications no. (%)</td><td align="left"/><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#x02003;&#x02003;Hemodynamic instability</td><td align="left">4 (5.2)</td><td align="left">2 (4.3)</td><td align="left">2 (6.5)</td><td char="." align="char">1.000</td></tr><tr><td align="left">&#x02003;&#x02003;Vomiting</td><td align="left">6 (7.8)</td><td align="left">3 (6.5)</td><td align="left">3 (9.7)</td><td char="." align="char">0.680</td></tr><tr><td align="left">&#x02003;&#x02003;Facial swelling</td><td align="left">12 (15.6)</td><td align="left">8 (17.4)</td><td align="left">4 (12.9)</td><td char="." align="char">0.832</td></tr><tr><td align="left"><bold>Cause of death</bold>,<bold> no. (%)</bold></td><td align="left"/><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#x02003;Sepsis</td><td align="left">10 (13.0)</td><td align="left">4 (8.7)</td><td align="left">6 (19.4)</td><td char="." align="char">0.172</td></tr><tr><td align="left">&#x02003;Pulmonary</td><td align="left">5 (6.5)</td><td align="left">2 (4.3)</td><td align="left">3 (9.7)</td><td char="." align="char">0.387</td></tr><tr><td align="left">&#x02003;Cardiac</td><td align="left">7 (9.1)</td><td align="left">4 (8.7)</td><td align="left">3 (9.7)</td><td char="." align="char">1.000</td></tr><tr><td align="left">&#x02003;Hepatic</td><td align="left">3 (3.9)</td><td align="left">1 (2.2)</td><td align="left">2 (6.5)</td><td char="." align="char">0.561</td></tr><tr><td align="left">&#x02003;Hemorrhage</td><td align="left">2 (2.6)</td><td align="left">1 (2.2)</td><td align="left">1 (3.2)</td><td char="." align="char">1.000</td></tr><tr><td align="left">&#x02003;Therapeutic limitations</td><td align="left">2 (2.6)</td><td align="left">1 (2.2)</td><td align="left">1 (3.2)</td><td char="." align="char">1.000</td></tr></tbody></table><table-wrap-foot><p>PP prone positioning, PaO<sub>2</sub>:FiO<sub>2</sub> ratio of the partial pressure of arterial oxygen to the fraction of inspired oxygen, PP prone positioning, ICU intensive care unit, ECMO extracorporeal membrane oxygenation, CRRT continuous renal replacement therapy</p></table-wrap-foot></table-wrap>
</p><p id="Par52">
<fig id="Fig6"><label>Fig. 6</label><caption><p>Probability of survival from day of study enrollment to day 28 in responders and non-responders</p></caption><graphic xlink:href="13613_2025_1489_Fig5_HTML" id="d33e2598"/></fig>
</p><p id="Par53">The length of the first PP session was similar between responders and non-responders (16 [range, 14&#x02013;16] hours vs. 16 [range, 14&#x02013;16] hours; <italic>P</italic>&#x02009;=&#x02009;0.196). The number of PP sessions per patient was also comparable between the two groups (3 [range, 3&#x02013;5] vs. 3 [range, 2&#x02013;5]; <italic>P</italic>&#x02009;=&#x02009;0.339). In addition, there were no significant differences in PP- related complications between responders and non-responders.</p><p id="Par54">The causes of death did not differ significantly between responders and non-responders. One patient in each group died after therapeutic limitations.</p></sec><sec id="Sec15"><title>Risk factors associated with ICU mortality</title><p id="Par55">Univariate analysis identified age, APACHE II scores, pre-PP driving pressure, and changes in post-PP driving pressure, PaO<sub>2</sub>/FiO<sub>2</sub>, compliance, shunt, dead space, and V/Q matching as significant predictors of ICU mortality (Table&#x000a0;<xref rid="Tab4" ref-type="table">4</xref>).</p><p id="Par56">
<table-wrap id="Tab4"><label>Table 4</label><caption><p>Risk factors associated with ICU mortality</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Variables</th><th align="left" colspan="3">Univariate logistic regression</th><th align="left" colspan="3">Multivariate logistic regression</th></tr><tr><th align="left">Odds ratios</th><th align="left">95% CI</th><th align="left">
<italic>P</italic>
</th><th align="left">Odds ratios</th><th align="left">95% CI</th><th align="left">
<italic>P</italic>
</th></tr></thead><tbody><tr><td align="left">
<bold>Study center</bold>
</td><td char="." align="char">1.036</td><td char="." align="char">0.370&#x02013;2.907</td><td char="." align="char">0.946</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">
<bold>Pre-PP</bold>
</td><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#x02003;Age</td><td char="." align="char">1.063</td><td char="." align="char">1.016&#x02013;1.112</td><td char="." align="char">0.008</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#x02003;Body mass index</td><td char="." align="char">1.037</td><td char="." align="char">0.862&#x02013;1.247</td><td char="." align="char">0.701</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#x02003;APACHE II score</td><td char="." align="char">1.090</td><td char="." align="char">1.003&#x02013;1.185</td><td char="." align="char">0.043</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#x02003;SOFA score</td><td char="." align="char">1.205</td><td char="." align="char">0.989&#x02013;1.468</td><td char="." align="char">0.064</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#x02003;ARDS severity</td><td char="." align="char">2.333</td><td char="." align="char">0.796&#x02013;6.837</td><td char="." align="char">0.122</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#x02003;Immunocompromised</td><td char="." align="char">3.828</td><td char="." align="char">0.979&#x02013;14.967</td><td char="." align="char">0.054</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#x02003;Lactate</td><td char="." align="char">1.166</td><td char="." align="char">0.679&#x02013;2.001</td><td char="." align="char">0.578</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#x02003;PaO<sub>2</sub>:FiO<sub>2</sub> ratio</td><td char="." align="char">0.980</td><td char="." align="char">0.957&#x02013;1.003</td><td char="." align="char">0.086</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#x02003;Driving pressure</td><td char="." align="char">1.262</td><td char="." align="char">1.052&#x02013;1.514</td><td char="." align="char">0.012</td><td char="." align="char">1.473</td><td char="." align="char">1.132&#x02013;1.916</td><td char="." align="char">0.004</td></tr><tr><td align="left">&#x02003;Compliance</td><td char="." align="char">0.941</td><td char="." align="char">0.878&#x02013;1.008</td><td char="." align="char">0.082</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">
<bold>Post-4-hour PP changes</bold>
</td><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#x02003;&#x00394; Driving pressure</td><td char="." align="char">2.016</td><td char="." align="char">1.201&#x02013;3.387</td><td char="." align="char">0.008</td><td char="." align="char">2.919</td><td char="." align="char">1.366&#x02013;6.236</td><td char="." align="char">0.006</td></tr><tr><td align="left">&#x02003;&#x00394; Compliance</td><td char="." align="char">0.770</td><td char="." align="char">0.621&#x02013;0.954</td><td char="." align="char">0.017</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#x02003;&#x00394; PaCO<sub>2</sub></td><td char="." align="char">1.068</td><td char="." align="char">0.761&#x02013;1.498</td><td char="." align="char">0.704</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#x02003;&#x00394; PaO<sub>2</sub>:FiO<sub>2</sub> ratio</td><td char="." align="char">0.982</td><td char="." align="char">0.965&#x02013;0.999</td><td char="." align="char">0.033</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#x02003;&#x00394; Shunt</td><td char="." align="char">1.061</td><td char="." align="char">1.004&#x02013;1.121</td><td char="." align="char">0.037</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#x02003;&#x00394; Dead space</td><td char="." align="char">1.082</td><td char="." align="char">1.014&#x02013;1.155</td><td char="." align="char">0.017</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#x02003;&#x00394; V/Q matching</td><td char="." align="char">0.832</td><td char="." align="char">0.745&#x02013;0.930</td><td char="." align="char">0.001</td><td char="." align="char">0.790</td><td char="." align="char">0.681&#x02013;0.917</td><td char="." align="char">0.002</td></tr></tbody></table><table-wrap-foot><p>PP prone positioning, APACHE II Acute Physiology and Chronic Health Evaluation II, SOFA sequential organ failure assessment, PaO<sub>2</sub>:FiO<sub>2</sub> ratio of the partial pressure of arterial oxygen to the fraction of inspired oxygen, &#x00394; changes after 4&#x000a0;h of prone positioning, PaCO<sub>2</sub> partial pressure of arterial carbon dioxide, V/Q ventilation/perfusion</p></table-wrap-foot></table-wrap>
</p><p id="Par57">Multivariate analysis confirmed that improved V/Q matching post-PP was protective against mortality (OR, 0.790; 95% CI, 0.681&#x02013;0.917; <italic>P</italic>&#x02009;=&#x02009;0.002). Meanwhile, higher pre-PP driving pressure (OR, 1.473; 95% CI, 1.132&#x02013;1.916; <italic>P</italic>&#x02009;=&#x02009;0.004) and increased post-PP driving pressure (OR, 2.919; 95% CI, 1.366&#x02013;2.236; <italic>P</italic>&#x02009;=&#x02009;0.006) were associated with higher mortality (Table&#x000a0;<xref rid="Tab4" ref-type="table">4</xref>).</p></sec></sec><sec id="Sec16"><title>Discussion</title><p id="Par58">To our knowledge, this is the first prospective observational study to explore the relationship between V/Q matching improvements following initial PP and ICU mortality in patients with moderate to severe ARDS. Through the use of EIT, we observed that: (1) PP led to significant enhancements in V/Q matching by reducing dorsal shunt and ventral dead space, with partial effects sustained after returning to the supine position; (2) responders showed lower ICU and 28-day mortality, more ventilator-free days at 28 days, and a reduced need for VV-ECMO than non-responders; (3) responders achieved greater physiological improvements, including higher PaO<sub>2</sub>/FiO<sub>2</sub> and more substantial reductions in shunt during PP than non-responders; and (4) enhanced V/Q matching was independently associated with lower ICU mortality.</p><p id="Par59">PP enhances V/Q matching by reducing shunt in the dorsal regions and minimizing dead space in the ventral regions [<xref ref-type="bibr" rid="CR26">26</xref>]. Our study found that this redistribution of ventilation and perfusion promotes alveolar recruitment in the well-perfused dorsal areas while relieving overdistension in the less-perfused ventral regions, resulting in an overall improvement in V/Q matching. These results are consistent with previous studies that demonstrated significant enhancements in V/Q matching with PP, highlighting its effectiveness in reducing the impact of pleural pressure gradient on ventilation and perfusion [<xref ref-type="bibr" rid="CR17">17</xref>&#x02013;<xref ref-type="bibr" rid="CR20">20</xref>]. While most studies have focused on changes in V/Q matching during the initial phase of PP [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR20">20</xref>], it is important to note that the effect of PP is time dependent [<xref ref-type="bibr" rid="CR27">27</xref>]. Our study addressed this limitation by monitoring changes in ventilation and perfusion throughout the prone session and after resupination. Notably, the improvement in V/Q matching observed during PP was partially maintained in the supine position, particularly in the dorsal regions. These findings contribute to a deeper understanding of PP as a dynamic and sustained intervention for optimizing V/Q matching in ARDS.</p><p id="Par60">The selection of 4&#x000a0;h within the first PP as the time point for defining responders and non-responders was based on a previous study and our clinical observations [<xref ref-type="bibr" rid="CR22">22</xref>]. That study reported the most pronounced PaO<sub>2</sub>/FiO<sub>2</sub> improvement within the first 4&#x000a0;h of PP, followed by a more gradual increase. Similarly, our study found that PaO<sub>2</sub>/FiO<sub>2</sub> rose from 113.2 mmHg to 162.0 mmHg within the first 4&#x000a0;h of PP, then increased more slowly, reaching 178.4 mmHg by the end of PP. Since PaO<sub>2</sub>/FiO<sub>2</sub> improvement largely depends on V/Q matching enhancement [<xref ref-type="bibr" rid="CR19">19</xref>], we hypothesized that the primary improvement in V/Q matching would also occur within the first 4&#x000a0;h of PP. Our findings confirmed this hypothesis, showing that V/Q matching improved predominantly within the first 4&#x000a0;h of PP, rising from 59.0% before PP to 71.2% at 4&#x000a0;h, with minimal further change thereafter, reaching 71.6% by the end of PP. Moreover, using the end of the PP session as the defining time point would introduce variability, as the duration of PP differed among patients. Therefore, selecting a fixed 4-hour time point ensured consistency and comparability across the study population.</p><p id="Par61">However, despite this general trend, the degree of V/Q matching improvement varied considerably among patients, indicating that not all individuals benefited equally from PP [<xref ref-type="bibr" rid="CR28">28</xref>]. In this study, 59.7% (46/77) of patients experienced a V/Q matching improvement greater than 10% from PP. Several factors may contribute to this heterogeneity. First, the etiology of ARDS plays a critical role. Patients with extrapulmonary ARDS often respond better to PP than those with pulmonary ARDS [<xref ref-type="bibr" rid="CR29">29</xref>]. This difference may be explained by the ability of PP to reverse compressive atelectasis in extrapulmonary ARDS, while its effects on consolidated lung units in pulmonary ARDS are more limited and less immediate [<xref ref-type="bibr" rid="CR30">30</xref>]. In our study, extrapulmonary ARDS was slightly more common among responders than non-responders (32.6% vs. 22.6%; <italic>P</italic>&#x02009;=&#x02009;0.339), suggesting a possible association between ARDS type and V/Q matching improvement. Second, the severity of illness may influence the response to PP. In more severe cases, reduced hypoxic vasoconstriction in the dorsal lung regions after oxygenation improvement could lead to a more pronounced decrease in dorsal shunt, resulting in greater V/Q matching improvement [<xref ref-type="bibr" rid="CR31">31</xref>]. This is further supported by our finding that moderate to severe ARDS was more frequently observed in responders than in non-responders (41.3% vs. 29.0%; <italic>P</italic>&#x02009;=&#x02009;0.272). Finally, the timing of PP initiation is a critical factor. A previous study showed that PP significantly reduces V/Q mismatch in patients with early ARDS but may worsen V/Q mismatch in those with persistent ARDS [<xref ref-type="bibr" rid="CR32">32</xref>]. In our study, all patients underwent PP shortly after the start of IMV, ensuring they were in the early phase of ARDS. As a result, most patients showed improvements in V/Q matching after PP, although the degree of improvement varied widely among patients.</p><p id="Par62">Our study found that responders had significantly lower ICU mortality than non-responders. This difference may be attributed to the larger areas of unmatched ventilation and perfusion observed in non-responders during PP, which could increase the risk of VILI. Non-responders often require higher pressures to recruit collapsed lung regions to reduce shunt [<xref ref-type="bibr" rid="CR33">33</xref>]. Simultaneously, increased minute ventilation is needed to compensate for alveolar hypoventilation caused by elevated dead space [<xref ref-type="bibr" rid="CR34">34</xref>]. These mechanical demands place significant stress and strain on the lungs, heightening the risk of overdistension, repetitive alveolar opening and closing, and the development of VILI [<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR36">36</xref>]. Furthermore, responders exhibited significantly higher PaO&#x02082;/FiO&#x02082; ratios than non-responders, a difference that persisted from PP to the period after resupination, potentially contributing to improved organ oxygen delivery. A previous study demonstrated that the percentage of unmatched lung units is an independent predictor of mortality in ARDS patients, consistent with our findings [<xref ref-type="bibr" rid="CR37">37</xref>]. This further supports the hypothesis that PP reduces mortality by improving V/Q matching and alleviating the physiological burden of ARDS.</p><p id="Par63">In this study, we found that PP reduced driving pressure and improved respiratory system compliance, with these effects becoming more evident as PP duration increased. Furthermore, the results of the GI index and the CoV confirmed that lung ventilation became more homogenous during PP. Previous studies have not consistently observed improvements in respiratory system compliance during PP [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR20">20</xref>]. A possible explanation is the relatively short duration of PP in those studies. In the early phase of PP, the increase in lung compliance may be insufficient to fully counterbalance the decline in chest wall compliance, leading to minimal or no changes in overall respiratory system compliance [<xref ref-type="bibr" rid="CR38">38</xref>]. However, studies with PP durations exceeding 12&#x000a0;h have shown significant improvements in respiratory system compliance compared with the supine position, aligning with our findings [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR39">39</xref>]. Moreover, our study found that higher pre-PP driving pressure and increased post-PP driving pressure were associated with higher mortality, consistent with the findings of previous research [<xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR41">41</xref>].</p><p id="Par64">This study found that, similar to ventilation, perfusion also undergoes a ventral-to-dorsal shift during PP, contributing to maximal improvement in V/Q matching. However, it has been suggested that gravity has a minimal effect on pulmonary blood flow, with the gravitational distribution being only slightly altered by turning prone [<xref ref-type="bibr" rid="CR42">42</xref>]. In the supine position, consolidation in the dependent dorsal regions leads to alveolar hypoxia, triggering hypoxic pulmonary vasoconstriction and redirecting blood flow to the better-ventilated nondependent ventral regions [<xref ref-type="bibr" rid="CR43">43</xref>]. During PP, the redistribution of blood flow directs it toward the now-dependent dorsal regions, which receive better ventilation in this position. The previously described mechanism explains the shift of blood flow from the ventral to the dorsal regions observed in our study during PP.</p><p id="Par65">We also observed that V/Q matching at 4&#x000a0;h within the first PP session was positively correlated with PaO<sub>2</sub>/FiO<sub>2</sub> and respiratory system compliance, suggesting that improved V/Q matching may contribute to better oxygenation and lung mechanics. These correlations remained moderate at the end of the session, indicating a potential lasting physiological effect. This finding is consistent with previous studies showing that improved V/Q matching is associated with better oxygenation [<xref ref-type="bibr" rid="CR19">19</xref>]. Since V/Q matching integrates data on ventilation and perfusion, it may provide complementary information to traditional respiratory parameters in identifying patients who are more likely to benefit from PP.</p><p id="Par66">In this study, PEEP was set using a decremental titration after a recruitment maneuver to achieve the highest respiratory system compliance in the supine position, and it remained constant during PP. This approach aimed to avoid changes in ventilation and perfusion caused by PEEP adjustments, ensuring a precise evaluation of the impact of PP. Notably, PP and PEEP may have synergistic effects. By reducing the heterogeneity of regional lung strain, PP could mitigate the regional hyperinflation associated with high PEEP levels [<xref ref-type="bibr" rid="CR4">4</xref>]. A recent study using EIT demonstrated that PEEP increases influenced V/Q matching through a balance between regional overdistension and recruitment [<xref ref-type="bibr" rid="CR44">44</xref>]. This highlights the complex interplay between PP and PEEP in improving V/Q matching in ARDS patients.</p><p id="Par67">The changes in V/Q matching observed during the first PP can help identify patients at greater risk for death, making it a valuable indicator for determining who may benefit from additional levels of assistance. Beyond PP, other interventions such as inhaled nitric oxide and VV-ECMO can also be considered to improve V/Q matching and oxygenation in ARDS patients [<xref ref-type="bibr" rid="CR45">45</xref>, <xref ref-type="bibr" rid="CR46">46</xref>]. In our study, three non-responders required VV-ECMO therapy, underscoring the importance of alternative strategies for patients who do not respond to PP.</p><p id="Par68">Beyond being the first study to explore the association between V/Q matching improvement with initial PP and ICU mortality in patients with moderate to severe ARDS, our study had several limitations. First, although this was a two-center prospective cohort study, the sample size was relatively small. We cannot exclude the possibility that the study was not adequately powered. Second, an EIT perfusion assessment using a saline bolus injection is still relatively new in clinical practice, although it has been validated in animal studies [<xref ref-type="bibr" rid="CR13">13</xref>&#x02013;<xref ref-type="bibr" rid="CR15">15</xref>]. Therefore, these findings should be generalized with caution. Third, EIT has limited spatial resolution and evaluates only the lung areas enclosed by the belt, which may not represent the entire pulmonary parenchyma. Fourth, we did not measure esophageal pressure to distinguish chest wall compliance from lung compliance. This may have restricted our ability to accurately assess individual changes in chest wall and lung compliance during PP. Fifth, transthoracic echocardiography was performed only in the supine position before and after PP, which may have limited the assessment of cardiac function and its influence on V/Q matching during PP [<xref ref-type="bibr" rid="CR47">47</xref>]. Last, as V/Q matching was assessed only during the first PP session, its ability to reflect the cumulative effect of multiple sessions remains unclear. Further studies are needed to evaluate whether responses to subsequent PP sessions could better predict outcomes.</p></sec><sec id="Sec17"><title>Conclusion</title><p id="Par69">In conclusion, our study suggests that improvement in V/Q matching 4&#x000a0;h within the first PP session may be associated with lower ICU mortality in patients with moderate to severe ARDS. PP not only enhanced V/Q matching but also promoted more homogenous ventilation and perfusion, improving respiratory mechanics. These results underscore the importance of PP in managing ARDS and highlight the need for further research to develop personalized PP approaches and evaluate complementary treatments.</p></sec><sec id="Sec18" sec-type="supplementary-material"><title>Electronic supplementary material</title><p>Below is the link to the electronic supplementary material.</p><p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="13613_2025_1489_MOESM1_ESM.docx"><caption><p>Supplementary Material 1: Additional file 1: 1. Online Table 1.1 Table S1. Comparison of ventilatory variables, arterial blood gas, hemodynamic status, and electrical impedance tomography between responder and non-responder groups during the first PP session. 1.2 Table S2 Changes in shunt, dead space, and V/Q matching 4 hours within the first PP in responders and non-responders. 1.3 Table S3 Comparison of echocardiographic variables between responders and non-responders in the supine position before and after PP. 2. Online Figures. 2.1 Figure S1 Flow chart. 2.2 Figure S2 Comparison of PEEP (A), tidal volume (B), driving pressure (C), and respiratory system compliance (D) between responders and non-responders during the first PP session. 2.3 Figure S3 Comparison of PaO<sub>2</sub> (A), PaCO<sub>2</sub> (B), PaO<sub>2</sub>/FiO<sub>2</sub> (C), and ventilatory ratio (D) between responders and non-responders during the first PP session. 2.4 Figure S4 Comparison of CVP (A) and ScvO<sub>2</sub> (B) between responders and non-responders during the first PP session. 2.5 Figure S5 Changes in ventilation (A) and perfusion (B) distribution across four ventral-to-dorsal horizontal regions during the first PP session.</p></caption></media></supplementary-material>
</p><p>
<supplementary-material content-type="local-data" id="MOESM2"><media xlink:href="13613_2025_1489_MOESM2_ESM.docx"><caption><p>Supplementary Material 2</p></caption></media></supplementary-material>
</p></sec></body><back><fn-group><fn><p><bold>Publisher&#x02019;s note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>None.</p></ack><notes notes-type="author-contribution"><title>Author contributions</title><p>RW contributed substantially to the study design, monitor and organize the study, recruited patients in the study, participated in acquisition and analysis of data, wrote the first draft of the manuscript and edited the manuscript after feedback from co-authors. WCW, XT, ZYQ, TL, YLL, HJL, JCY, HY, WRL, ZHL, and BS contributed substantially to treated patients in the study, participated in acquisition of data, and provided revisions to the manuscript. GFG contributed substantially to the study design, monitor and organize the study, recruited patients in the study, wrote the first draft of the manuscript and edited the manuscript after feedback from co-authors.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>This work was supported by Reform and Development Program of the Beijing Institute of Respiratory Medicine (Ggyfz202413), and the Beijing Municipal Administration of Hospitals Incubating Program (PX2023010).</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>The data are available from the corresponding author on reasonable request.</p></notes><notes><title>Declarations</title><notes id="FPar1"><title>Ethics approval and consent to participate</title><p id="Par70">This study is approved by the ethics committee of Beijing Chao-Yang Hospital and Qinghai University Affiliated Hospital.</p></notes><notes id="FPar2"><title>Consent for publication</title><p id="Par71">Consent for publication was obtained for this report.</p></notes><notes id="FPar3" notes-type="COI-statement"><title>Conflict of interest</title><p id="Par72">All named authors declare that they have no conflicts of interests.</p></notes></notes><glossary><title>Abbreviations</title><def-list><def-item><term>PP</term><def><p id="Par73">Prone positioning</p></def></def-item><def-item><term>ARDS</term><def><p id="Par74">Acute respiratory distress syndrome</p></def></def-item><def-item><term>VILI</term><def><p id="Par75">Ventilation-induced lung injury</p></def></def-item><def-item><term>V/Q</term><def><p id="Par76">Ventilation-perfusion</p></def></def-item><def-item><term>EIT</term><def><p id="Par77">Electrical impedance tomography</p></def></def-item><def-item><term>ICU</term><def><p id="Par78">Intensive care unit</p></def></def-item><def-item><term>PaO&#x02082;</term><def><p id="Par79">Partial pressure of arterial oxygen</p></def></def-item><def-item><term>FiO&#x02082;</term><def><p id="Par80">Fraction of inspired oxygen</p></def></def-item><def-item><term>BMI</term><def><p id="Par81">Body mass index</p></def></def-item><def-item><term>IMV</term><def><p id="Par82">Invasive mechanical ventilation</p></def></def-item><def-item><term>VV-ECMO</term><def><p id="Par83">Venovenous extracorporeal membrane oxygenation</p></def></def-item><def-item><term>PEEP</term><def><p id="Par84">Positive end-expiratory pressure</p></def></def-item><def-item><term>SpO<sub>2</sub></term><def><p id="Par85">Oxygen saturation</p></def></def-item><def-item><term>ROIs</term><def><p id="Par86">Regions of interest</p></def></def-item><def-item><term>GI</term><def><p id="Par87">Global inhomogeneity</p></def></def-item><def-item><term>CoV</term><def><p id="Par88">Center of ventilation</p></def></def-item><def-item><term>CRRT</term><def><p id="Par89">Continuous renal replacement therapy</p></def></def-item><def-item><term>ANOVA</term><def><p id="Par90">Analysis of variance</p></def></def-item><def-item><term>PaCO<sub>2</sub></term><def><p id="Par91">Partial pressure of arterial carbon dioxide</p></def></def-item><def-item><term>CVP</term><def><p id="Par92">Central venous pressure</p></def></def-item><def-item><term>ScvO<sub>2</sub></term><def><p id="Par93">Central venous oxygen saturation</p></def></def-item></def-list></glossary><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name><surname>Guerin</surname><given-names>C</given-names></name><name><surname>Reignier</surname><given-names>J</given-names></name><name><surname>Richard</surname><given-names>JC</given-names></name><name><surname>Beuret</surname><given-names>P</given-names></name><name><surname>Gacouin</surname><given-names>A</given-names></name><name><surname>Boulain</surname><given-names>T</given-names></name><name><surname>Mercier</surname><given-names>E</given-names></name><name><surname>Badet</surname><given-names>M</given-names></name><name><surname>Mercat</surname><given-names>A</given-names></name><name><surname>Baudin</surname><given-names>O</given-names></name><etal/></person-group><article-title>Prone positioning in severe acute respiratory distress syndrome</article-title><source>N Engl J Med</source><year>2013</year><volume>368</volume><issue>23</issue><fpage>2159</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1214103</pub-id><pub-id pub-id-type="pmid">23688302</pub-id>
</element-citation><mixed-citation id="mc-CR1" publication-type="journal">Guerin C, Reignier J, Richard JC, Beuret P, Gacouin A, Boulain T, Mercier E, Badet M, Mercat A, Baudin O, et al. Prone positioning in severe acute respiratory distress syndrome. N Engl J Med. 2013;368(23):2159&#x02013;68.<pub-id pub-id-type="pmid">23688302</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name><surname>Langer</surname><given-names>T</given-names></name><name><surname>Brioni</surname><given-names>M</given-names></name><name><surname>Guzzardella</surname><given-names>A</given-names></name><name><surname>Carlesso</surname><given-names>E</given-names></name><name><surname>Cabrini</surname><given-names>L</given-names></name><name><surname>Castelli</surname><given-names>G</given-names></name><name><surname>Dalla Corte</surname><given-names>F</given-names></name><name><surname>De Robertis</surname><given-names>E</given-names></name><name><surname>Favarato</surname><given-names>M</given-names></name><name><surname>Forastieri</surname><given-names>A</given-names></name><etal/></person-group><article-title>Prone position in intubated, mechanically ventilated patients with COVID-19: a multi-centric study of more than 1000 patients</article-title><source>Crit Care</source><year>2021</year><volume>25</volume><issue>1</issue><fpage>128</fpage><pub-id pub-id-type="doi">10.1186/s13054-021-03552-2</pub-id><pub-id pub-id-type="pmid">33823862</pub-id>
</element-citation><mixed-citation id="mc-CR2" publication-type="journal">Langer T, Brioni M, Guzzardella A, Carlesso E, Cabrini L, Castelli G, Dalla Corte F, De Robertis E, Favarato M, Forastieri A, et al. Prone position in intubated, mechanically ventilated patients with COVID-19: a multi-centric study of more than 1000 patients. Crit Care. 2021;25(1):128.<pub-id pub-id-type="pmid">33823862</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name><surname>Mathews</surname><given-names>KS</given-names></name><name><surname>Soh</surname><given-names>H</given-names></name><name><surname>Shaefi</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Bose</surname><given-names>S</given-names></name><name><surname>Coca</surname><given-names>S</given-names></name><name><surname>Gupta</surname><given-names>S</given-names></name><name><surname>Hayek</surname><given-names>SS</given-names></name><name><surname>Srivastava</surname><given-names>A</given-names></name><name><surname>Brenner</surname><given-names>SK</given-names></name><etal/></person-group><article-title>Prone positioning and survival in mechanically ventilated patients with coronavirus disease 2019-Related respiratory failure</article-title><source>Crit Care Med</source><year>2021</year><volume>49</volume><issue>7</issue><fpage>1026</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1097/CCM.0000000000004938</pub-id><pub-id pub-id-type="pmid">33595960</pub-id>
</element-citation><mixed-citation id="mc-CR3" publication-type="journal">Mathews KS, Soh H, Shaefi S, Wang W, Bose S, Coca S, Gupta S, Hayek SS, Srivastava A, Brenner SK, et al. Prone positioning and survival in mechanically ventilated patients with coronavirus disease 2019-Related respiratory failure. Crit Care Med. 2021;49(7):1026&#x02013;37.<pub-id pub-id-type="pmid">33595960</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name><surname>Cornejo</surname><given-names>RA</given-names></name><name><surname>Diaz</surname><given-names>JC</given-names></name><name><surname>Tobar</surname><given-names>EA</given-names></name><name><surname>Bruhn</surname><given-names>AR</given-names></name><name><surname>Ramos</surname><given-names>CA</given-names></name><name><surname>Gonzalez</surname><given-names>RA</given-names></name><name><surname>Repetto</surname><given-names>CA</given-names></name><name><surname>Romero</surname><given-names>CM</given-names></name><name><surname>Galvez</surname><given-names>LR</given-names></name><name><surname>Llanos</surname><given-names>O</given-names></name><etal/></person-group><article-title>Effects of prone positioning on lung protection in patients with acute respiratory distress syndrome</article-title><source>Am J Respir Crit Care Med</source><year>2013</year><volume>188</volume><issue>4</issue><fpage>440</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1164/rccm.201207-1279OC</pub-id><pub-id pub-id-type="pmid">23348974</pub-id>
</element-citation><mixed-citation id="mc-CR4" publication-type="journal">Cornejo RA, Diaz JC, Tobar EA, Bruhn AR, Ramos CA, Gonzalez RA, Repetto CA, Romero CM, Galvez LR, Llanos O, et al. Effects of prone positioning on lung protection in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med. 2013;188(4):440&#x02013;8.<pub-id pub-id-type="pmid">23348974</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name><surname>Gattinoni</surname><given-names>L</given-names></name><name><surname>Taccone</surname><given-names>P</given-names></name><name><surname>Carlesso</surname><given-names>E</given-names></name><name><surname>Marini</surname><given-names>JJ</given-names></name></person-group><article-title>Prone position in acute respiratory distress syndrome. Rationale, indications, and limits</article-title><source>Am J Respir Crit Care Med</source><year>2013</year><volume>188</volume><issue>11</issue><fpage>1286</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1164/rccm.201308-1532CI</pub-id><pub-id pub-id-type="pmid">24134414</pub-id>
</element-citation><mixed-citation id="mc-CR5" publication-type="journal">Gattinoni L, Taccone P, Carlesso E, Marini JJ. Prone position in acute respiratory distress syndrome. Rationale, indications, and limits. Am J Respir Crit Care Med. 2013;188(11):1286&#x02013;93.<pub-id pub-id-type="pmid">24134414</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name><surname>Gattinoni</surname><given-names>L</given-names></name><name><surname>Tognoni</surname><given-names>G</given-names></name><name><surname>Pesenti</surname><given-names>A</given-names></name><name><surname>Taccone</surname><given-names>P</given-names></name><name><surname>Mascheroni</surname><given-names>D</given-names></name><name><surname>Labarta</surname><given-names>V</given-names></name><name><surname>Malacrida</surname><given-names>R</given-names></name><name><surname>Di Giulio</surname><given-names>P</given-names></name><name><surname>Fumagalli</surname><given-names>R</given-names></name><name><surname>Pelosi</surname><given-names>P</given-names></name><etal/></person-group><article-title>Effect of prone positioning on the survival of patients with acute respiratory failure</article-title><source>N Engl J Med</source><year>2001</year><volume>345</volume><issue>8</issue><fpage>568</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa010043</pub-id><pub-id pub-id-type="pmid">11529210</pub-id>
</element-citation><mixed-citation id="mc-CR6" publication-type="journal">Gattinoni L, Tognoni G, Pesenti A, Taccone P, Mascheroni D, Labarta V, Malacrida R, Di Giulio P, Fumagalli R, Pelosi P, et al. Effect of prone positioning on the survival of patients with acute respiratory failure. N Engl J Med. 2001;345(8):568&#x02013;73.<pub-id pub-id-type="pmid">11529210</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name><surname>Guerin</surname><given-names>C</given-names></name><name><surname>Gaillard</surname><given-names>S</given-names></name><name><surname>Lemasson</surname><given-names>S</given-names></name><name><surname>Ayzac</surname><given-names>L</given-names></name><name><surname>Girard</surname><given-names>R</given-names></name><name><surname>Beuret</surname><given-names>P</given-names></name><name><surname>Palmier</surname><given-names>B</given-names></name><name><surname>Le</surname><given-names>QV</given-names></name><name><surname>Sirodot</surname><given-names>M</given-names></name><name><surname>Rosselli</surname><given-names>S</given-names></name><etal/></person-group><article-title>Effects of systematic prone positioning in hypoxemic acute respiratory failure: a randomized controlled trial</article-title><source>JAMA</source><year>2004</year><volume>292</volume><issue>19</issue><fpage>2379</fpage><lpage>87</lpage><pub-id pub-id-type="doi">10.1001/jama.292.19.2379</pub-id><pub-id pub-id-type="pmid">15547166</pub-id>
</element-citation><mixed-citation id="mc-CR7" publication-type="journal">Guerin C, Gaillard S, Lemasson S, Ayzac L, Girard R, Beuret P, Palmier B, Le QV, Sirodot M, Rosselli S, et al. Effects of systematic prone positioning in hypoxemic acute respiratory failure: a randomized controlled trial. JAMA. 2004;292(19):2379&#x02013;87.<pub-id pub-id-type="pmid">15547166</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name><surname>Mancebo</surname><given-names>J</given-names></name><name><surname>Fernandez</surname><given-names>R</given-names></name><name><surname>Blanch</surname><given-names>L</given-names></name><name><surname>Rialp</surname><given-names>G</given-names></name><name><surname>Gordo</surname><given-names>F</given-names></name><name><surname>Ferrer</surname><given-names>M</given-names></name><name><surname>Rodriguez</surname><given-names>F</given-names></name><name><surname>Garro</surname><given-names>P</given-names></name><name><surname>Ricart</surname><given-names>P</given-names></name><name><surname>Vallverdu</surname><given-names>I</given-names></name><etal/></person-group><article-title>A multicenter trial of prolonged prone ventilation in severe acute respiratory distress syndrome</article-title><source>Am J Respir Crit Care Med</source><year>2006</year><volume>173</volume><issue>11</issue><fpage>1233</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1164/rccm.200503-353OC</pub-id><pub-id pub-id-type="pmid">16556697</pub-id>
</element-citation><mixed-citation id="mc-CR8" publication-type="journal">Mancebo J, Fernandez R, Blanch L, Rialp G, Gordo F, Ferrer M, Rodriguez F, Garro P, Ricart P, Vallverdu I, et al. A multicenter trial of prolonged prone ventilation in severe acute respiratory distress syndrome. Am J Respir Crit Care Med. 2006;173(11):1233&#x02013;9.<pub-id pub-id-type="pmid">16556697</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name><surname>Taccone</surname><given-names>P</given-names></name><name><surname>Pesenti</surname><given-names>A</given-names></name><name><surname>Latini</surname><given-names>R</given-names></name><name><surname>Polli</surname><given-names>F</given-names></name><name><surname>Vagginelli</surname><given-names>F</given-names></name><name><surname>Mietto</surname><given-names>C</given-names></name><name><surname>Caspani</surname><given-names>L</given-names></name><name><surname>Raimondi</surname><given-names>F</given-names></name><name><surname>Bordone</surname><given-names>G</given-names></name><name><surname>Iapichino</surname><given-names>G</given-names></name><etal/></person-group><article-title>Prone positioning in patients with moderate and severe acute respiratory distress syndrome: a randomized controlled trial</article-title><source>JAMA</source><year>2009</year><volume>302</volume><issue>18</issue><fpage>1977</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1001/jama.2009.1614</pub-id><pub-id pub-id-type="pmid">19903918</pub-id>
</element-citation><mixed-citation id="mc-CR9" publication-type="journal">Taccone P, Pesenti A, Latini R, Polli F, Vagginelli F, Mietto C, Caspani L, Raimondi F, Bordone G, Iapichino G, et al. Prone positioning in patients with moderate and severe acute respiratory distress syndrome: a randomized controlled trial. JAMA. 2009;302(18):1977&#x02013;84.<pub-id pub-id-type="pmid">19903918</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name><surname>Frerichs</surname><given-names>I</given-names></name><name><surname>Amato</surname><given-names>MB</given-names></name><name><surname>van Kaam</surname><given-names>AH</given-names></name><name><surname>Tingay</surname><given-names>DG</given-names></name><name><surname>Zhao</surname><given-names>Z</given-names></name><name><surname>Grychtol</surname><given-names>B</given-names></name><name><surname>Bodenstein</surname><given-names>M</given-names></name><name><surname>Gagnon</surname><given-names>H</given-names></name><name><surname>Bohm</surname><given-names>SH</given-names></name><name><surname>Teschner</surname><given-names>E</given-names></name><etal/></person-group><article-title>Chest electrical impedance tomography examination, data analysis, terminology, clinical use and recommendations: consensus statement of the translational EIT development study group</article-title><source>Thorax</source><year>2017</year><volume>72</volume><issue>1</issue><fpage>83</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1136/thoraxjnl-2016-208357</pub-id><pub-id pub-id-type="pmid">27596161</pub-id>
</element-citation><mixed-citation id="mc-CR10" publication-type="journal">Frerichs I, Amato MB, van Kaam AH, Tingay DG, Zhao Z, Grychtol B, Bodenstein M, Gagnon H, Bohm SH, Teschner E, et al. Chest electrical impedance tomography examination, data analysis, terminology, clinical use and recommendations: consensus statement of the translational EIT development study group. Thorax. 2017;72(1):83&#x02013;93.<pub-id pub-id-type="pmid">27596161</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name><surname>Jimenez</surname><given-names>JV</given-names></name><name><surname>Weirauch</surname><given-names>AJ</given-names></name><name><surname>Culter</surname><given-names>CA</given-names></name><name><surname>Choi</surname><given-names>PJ</given-names></name><name><surname>Hyzy</surname><given-names>RC</given-names></name></person-group><article-title>Electrical impedance tomography in acute respiratory distress syndrome management</article-title><source>Crit Care Med</source><year>2022</year><volume>50</volume><issue>8</issue><fpage>1210</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1097/CCM.0000000000005582</pub-id><pub-id pub-id-type="pmid">35607967</pub-id>
</element-citation><mixed-citation id="mc-CR11" publication-type="journal">Jimenez JV, Weirauch AJ, Culter CA, Choi PJ, Hyzy RC. Electrical impedance tomography in acute respiratory distress syndrome management. Crit Care Med. 2022;50(8):1210&#x02013;23.<pub-id pub-id-type="pmid">35607967</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name><surname>Scaramuzzo</surname><given-names>G</given-names></name><name><surname>Pavlovsky</surname><given-names>B</given-names></name><name><surname>Adler</surname><given-names>A</given-names></name><name><surname>Baccinelli</surname><given-names>W</given-names></name><name><surname>Bodor</surname><given-names>DL</given-names></name><name><surname>Damiani</surname><given-names>LF</given-names></name><name><surname>Franchineau</surname><given-names>G</given-names></name><name><surname>Francovich</surname><given-names>J</given-names></name><name><surname>Frerichs</surname><given-names>I</given-names></name><name><surname>Giralt</surname><given-names>JAS</given-names></name><etal/></person-group><article-title>Electrical impedance tomography monitoring in adult ICU patients: state-of-the-art, recommendations for standardized acquisition, processing, and clinical use, and future directions</article-title><source>Crit Care</source><year>2024</year><volume>28</volume><issue>1</issue><fpage>377</fpage><pub-id pub-id-type="doi">10.1186/s13054-024-05173-x</pub-id><pub-id pub-id-type="pmid">39563476</pub-id>
</element-citation><mixed-citation id="mc-CR12" publication-type="journal">Scaramuzzo G, Pavlovsky B, Adler A, Baccinelli W, Bodor DL, Damiani LF, Franchineau G, Francovich J, Frerichs I, Giralt JAS, et al. Electrical impedance tomography monitoring in adult ICU patients: state-of-the-art, recommendations for standardized acquisition, processing, and clinical use, and future directions. Crit Care. 2024;28(1):377.<pub-id pub-id-type="pmid">39563476</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name><surname>Bluth</surname><given-names>T</given-names></name><name><surname>Kiss</surname><given-names>T</given-names></name><name><surname>Kircher</surname><given-names>M</given-names></name><name><surname>Braune</surname><given-names>A</given-names></name><name><surname>Bozsak</surname><given-names>C</given-names></name><name><surname>Huhle</surname><given-names>R</given-names></name><name><surname>Scharffenberg</surname><given-names>M</given-names></name><name><surname>Herzog</surname><given-names>M</given-names></name><name><surname>Roegner</surname><given-names>J</given-names></name><name><surname>Herzog</surname><given-names>P</given-names></name><etal/></person-group><article-title>Measurement of relative lung perfusion with electrical impedance and positron emission tomography: an experimental comparative study in pigs</article-title><source>Br J Anaesth</source><year>2019</year><volume>123</volume><issue>2</issue><fpage>246</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1016/j.bja.2019.04.056</pub-id><pub-id pub-id-type="pmid">31160064</pub-id>
</element-citation><mixed-citation id="mc-CR13" publication-type="journal">Bluth T, Kiss T, Kircher M, Braune A, Bozsak C, Huhle R, Scharffenberg M, Herzog M, Roegner J, Herzog P, et al. Measurement of relative lung perfusion with electrical impedance and positron emission tomography: an experimental comparative study in pigs. Br J Anaesth. 2019;123(2):246&#x02013;54.<pub-id pub-id-type="pmid">31160064</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name><surname>Borges</surname><given-names>JB</given-names></name><name><surname>Cronin</surname><given-names>JN</given-names></name><name><surname>Crockett</surname><given-names>DC</given-names></name><name><surname>Hedenstierna</surname><given-names>G</given-names></name><name><surname>Larsson</surname><given-names>A</given-names></name><name><surname>Formenti</surname><given-names>F</given-names></name></person-group><article-title>Real-time effects of PEEP and tidal volume on regional ventilation and perfusion in experimental lung injury</article-title><source>Intensive Care Med Exp</source><year>2020</year><volume>8</volume><issue>1</issue><fpage>10</fpage><pub-id pub-id-type="doi">10.1186/s40635-020-0298-2</pub-id><pub-id pub-id-type="pmid">32086632</pub-id>
</element-citation><mixed-citation id="mc-CR14" publication-type="journal">Borges JB, Cronin JN, Crockett DC, Hedenstierna G, Larsson A, Formenti F. Real-time effects of PEEP and tidal volume on regional ventilation and perfusion in experimental lung injury. Intensive Care Med Exp. 2020;8(1):10.<pub-id pub-id-type="pmid">32086632</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name><surname>Kircher</surname><given-names>M</given-names></name><name><surname>Elke</surname><given-names>G</given-names></name><name><surname>Stender</surname><given-names>B</given-names></name><name><surname>Hernandez Mesa</surname><given-names>M</given-names></name><name><surname>Schuderer</surname><given-names>F</given-names></name><name><surname>Dossel</surname><given-names>O</given-names></name><name><surname>Fuld</surname><given-names>MK</given-names></name><name><surname>Halaweish</surname><given-names>AF</given-names></name><name><surname>Hoffman</surname><given-names>EA</given-names></name><name><surname>Weiler</surname><given-names>N</given-names></name><etal/></person-group><article-title>Regional lung perfusion analysis in experimental ARDS by electrical impedance and computed tomography</article-title><source>IEEE Trans Med Imaging</source><year>2021</year><volume>40</volume><issue>1</issue><fpage>251</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1109/TMI.2020.3025080</pub-id><pub-id pub-id-type="pmid">32956046</pub-id>
</element-citation><mixed-citation id="mc-CR15" publication-type="journal">Kircher M, Elke G, Stender B, Hernandez Mesa M, Schuderer F, Dossel O, Fuld MK, Halaweish AF, Hoffman EA, Weiler N, et al. Regional lung perfusion analysis in experimental ARDS by electrical impedance and computed tomography. IEEE Trans Med Imaging. 2021;40(1):251&#x02013;61.<pub-id pub-id-type="pmid">32956046</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name><surname>Rampon</surname><given-names>GL</given-names></name><name><surname>Simpson</surname><given-names>SQ</given-names></name><name><surname>Agrawal</surname><given-names>R</given-names></name></person-group><article-title>Prone positioning for acute hypoxemic respiratory failure and ARDS: A review</article-title><source>Chest</source><year>2023</year><volume>163</volume><issue>2</issue><fpage>332</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1016/j.chest.2022.09.020</pub-id><pub-id pub-id-type="pmid">36162482</pub-id>
</element-citation><mixed-citation id="mc-CR16" publication-type="journal">Rampon GL, Simpson SQ, Agrawal R. Prone positioning for acute hypoxemic respiratory failure and ARDS: A review. Chest. 2023;163(2):332&#x02013;40.<pub-id pub-id-type="pmid">36162482</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name><surname>Fossali</surname><given-names>T</given-names></name><name><surname>Pavlovsky</surname><given-names>B</given-names></name><name><surname>Ottolina</surname><given-names>D</given-names></name><name><surname>Colombo</surname><given-names>R</given-names></name><name><surname>Basile</surname><given-names>MC</given-names></name><name><surname>Castelli</surname><given-names>A</given-names></name><name><surname>Rech</surname><given-names>R</given-names></name><name><surname>Borghi</surname><given-names>B</given-names></name><name><surname>Ianniello</surname><given-names>A</given-names></name><name><surname>Flor</surname><given-names>N</given-names></name><etal/></person-group><article-title>Effects of prone position on lung recruitment and Ventilation-Perfusion matching in patients with COVID-19 acute respiratory distress syndrome: A combined CT scan/electrical impedance tomography study</article-title><source>Crit Care Med</source><year>2022</year><volume>50</volume><issue>5</issue><fpage>723</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1097/CCM.0000000000005450</pub-id><pub-id pub-id-type="pmid">35200194</pub-id>
</element-citation><mixed-citation id="mc-CR17" publication-type="journal">Fossali T, Pavlovsky B, Ottolina D, Colombo R, Basile MC, Castelli A, Rech R, Borghi B, Ianniello A, Flor N, et al. Effects of prone position on lung recruitment and Ventilation-Perfusion matching in patients with COVID-19 acute respiratory distress syndrome: A combined CT scan/electrical impedance tomography study. Crit Care Med. 2022;50(5):723&#x02013;32.<pub-id pub-id-type="pmid">35200194</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name><surname>Perier</surname><given-names>F</given-names></name><name><surname>Tuffet</surname><given-names>S</given-names></name><name><surname>Maraffi</surname><given-names>T</given-names></name><name><surname>Alcala</surname><given-names>G</given-names></name><name><surname>Victor</surname><given-names>M</given-names></name><name><surname>Haudebourg</surname><given-names>AF</given-names></name><name><surname>De Prost</surname><given-names>N</given-names></name><name><surname>Amato</surname><given-names>M</given-names></name><name><surname>Carteaux</surname><given-names>G</given-names></name><name><surname>Mekontso Dessap</surname><given-names>A</given-names></name></person-group><article-title>Effect of positive End-Expiratory pressure and proning on ventilation and perfusion in COVID-19 acute respiratory distress syndrome</article-title><source>Am J Respir Crit Care Med</source><year>2020</year><volume>202</volume><issue>12</issue><fpage>1713</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1164/rccm.202008-3058LE</pub-id><pub-id pub-id-type="pmid">33075235</pub-id>
</element-citation><mixed-citation id="mc-CR18" publication-type="journal">Perier F, Tuffet S, Maraffi T, Alcala G, Victor M, Haudebourg AF, De Prost N, Amato M, Carteaux G, Mekontso Dessap A. Effect of positive End-Expiratory pressure and proning on ventilation and perfusion in COVID-19 acute respiratory distress syndrome. Am J Respir Crit Care Med. 2020;202(12):1713&#x02013;7.<pub-id pub-id-type="pmid">33075235</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>YX</given-names></name><name><surname>Zhong</surname><given-names>M</given-names></name><name><surname>Dong</surname><given-names>MH</given-names></name><name><surname>Song</surname><given-names>JQ</given-names></name><name><surname>Zheng</surname><given-names>YJ</given-names></name><name><surname>Wu</surname><given-names>W</given-names></name><name><surname>Tao</surname><given-names>JL</given-names></name><name><surname>Zhu</surname><given-names>L</given-names></name><name><surname>Zheng</surname><given-names>X</given-names></name></person-group><article-title>Prone positioning improves ventilation-perfusion matching assessed by electrical impedance tomography in patients with ARDS: a prospective physiological study</article-title><source>Crit Care</source><year>2022</year><volume>26</volume><issue>1</issue><fpage>154</fpage><pub-id pub-id-type="doi">10.1186/s13054-022-04021-0</pub-id><pub-id pub-id-type="pmid">35624489</pub-id>
</element-citation><mixed-citation id="mc-CR19" publication-type="journal">Wang YX, Zhong M, Dong MH, Song JQ, Zheng YJ, Wu W, Tao JL, Zhu L, Zheng X. Prone positioning improves ventilation-perfusion matching assessed by electrical impedance tomography in patients with ARDS: a prospective physiological study. Crit Care. 2022;26(1):154.<pub-id pub-id-type="pmid">35624489</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name><surname>Zarantonello</surname><given-names>F</given-names></name><name><surname>Sella</surname><given-names>N</given-names></name><name><surname>Pettenuzzo</surname><given-names>T</given-names></name><name><surname>Andreatta</surname><given-names>G</given-names></name><name><surname>Calore</surname><given-names>A</given-names></name><name><surname>Dotto</surname><given-names>D</given-names></name><name><surname>De Cassai</surname><given-names>A</given-names></name><name><surname>Calabrese</surname><given-names>F</given-names></name><name><surname>Boscolo</surname><given-names>A</given-names></name><name><surname>Navalesi</surname><given-names>P</given-names></name></person-group><article-title>Early physiologic effects of prone positioning in COVID-19 acute respiratory distress syndrome</article-title><source>Anesthesiology</source><year>2022</year><volume>137</volume><issue>3</issue><fpage>327</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1097/ALN.0000000000004296</pub-id><pub-id pub-id-type="pmid">35708999</pub-id>
</element-citation><mixed-citation id="mc-CR20" publication-type="journal">Zarantonello F, Sella N, Pettenuzzo T, Andreatta G, Calore A, Dotto D, De Cassai A, Calabrese F, Boscolo A, Navalesi P. Early physiologic effects of prone positioning in COVID-19 acute respiratory distress syndrome. Anesthesiology. 2022;137(3):327&#x02013;39.<pub-id pub-id-type="pmid">35708999</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name><surname>Force</surname><given-names>ADT</given-names></name><name><surname>Ranieri</surname><given-names>VM</given-names></name><name><surname>Rubenfeld</surname><given-names>GD</given-names></name><name><surname>Thompson</surname><given-names>BT</given-names></name><name><surname>Ferguson</surname><given-names>ND</given-names></name><name><surname>Caldwell</surname><given-names>E</given-names></name><name><surname>Fan</surname><given-names>E</given-names></name><name><surname>Camporota</surname><given-names>L</given-names></name><name><surname>Slutsky</surname><given-names>AS</given-names></name></person-group><article-title>Acute respiratory distress syndrome: the Berlin definition</article-title><source>JAMA</source><year>2012</year><volume>307</volume><issue>23</issue><fpage>2526</fpage><lpage>33</lpage><pub-id pub-id-type="pmid">22797452</pub-id>
</element-citation><mixed-citation id="mc-CR21" publication-type="journal">Force ADT, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, Camporota L, Slutsky AS. Acute respiratory distress syndrome: the Berlin definition. JAMA. 2012;307(23):2526&#x02013;33.<pub-id pub-id-type="pmid">22797452</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>HY</given-names></name><name><surname>Cho</surname><given-names>J</given-names></name><name><surname>Kwak</surname><given-names>N</given-names></name><name><surname>Choi</surname><given-names>SM</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Park</surname><given-names>YS</given-names></name><name><surname>Lee</surname><given-names>CH</given-names></name><name><surname>Yoo</surname><given-names>CG</given-names></name><name><surname>Kim</surname><given-names>YW</given-names></name><name><surname>Lee</surname><given-names>SM</given-names></name></person-group><article-title>Improved oxygenation after prone positioning May be a predictor of survival in patients with acute respiratory distress syndrome</article-title><source>Crit Care Med</source><year>2020</year><volume>48</volume><issue>12</issue><fpage>1729</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1097/CCM.0000000000004611</pub-id><pub-id pub-id-type="pmid">33003079</pub-id>
</element-citation><mixed-citation id="mc-CR22" publication-type="journal">Lee HY, Cho J, Kwak N, Choi SM, Lee J, Park YS, Lee CH, Yoo CG, Kim YW, Lee SM. Improved oxygenation after prone positioning May be a predictor of survival in patients with acute respiratory distress syndrome. Crit Care Med. 2020;48(12):1729&#x02013;36.<pub-id pub-id-type="pmid">33003079</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>H</given-names></name><name><surname>Long</surname><given-names>Y</given-names></name><name><surname>Frerichs</surname><given-names>I</given-names></name><name><surname>Zhao</surname><given-names>Z</given-names></name></person-group><article-title>Detection of acute pulmonary embolism by electrical impedance tomography and saline bolus injection</article-title><source>Am J Respir Crit Care Med</source><year>2020</year><volume>202</volume><issue>6</issue><fpage>881</fpage><lpage>2</lpage><pub-id pub-id-type="doi">10.1164/rccm.202003-0554IM</pub-id><pub-id pub-id-type="pmid">32469613</pub-id>
</element-citation><mixed-citation id="mc-CR23" publication-type="journal">He H, Long Y, Frerichs I, Zhao Z. Detection of acute pulmonary embolism by electrical impedance tomography and saline bolus injection. Am J Respir Crit Care Med. 2020;202(6):881&#x02013;2.<pub-id pub-id-type="pmid">32469613</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>Z</given-names></name><name><surname>Moller</surname><given-names>K</given-names></name><name><surname>Steinmann</surname><given-names>D</given-names></name><name><surname>Frerichs</surname><given-names>I</given-names></name><name><surname>Guttmann</surname><given-names>J</given-names></name></person-group><article-title>Evaluation of an electrical impedance tomography-based global inhomogeneity index for pulmonary ventilation distribution</article-title><source>Intensive Care Med</source><year>2009</year><volume>35</volume><issue>11</issue><fpage>1900</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1007/s00134-009-1589-y</pub-id><pub-id pub-id-type="pmid">19652949</pub-id>
</element-citation><mixed-citation id="mc-CR24" publication-type="journal">Zhao Z, Moller K, Steinmann D, Frerichs I, Guttmann J. Evaluation of an electrical impedance tomography-based global inhomogeneity index for pulmonary ventilation distribution. Intensive Care Med. 2009;35(11):1900&#x02013;6.<pub-id pub-id-type="pmid">19652949</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshida</surname><given-names>T</given-names></name><name><surname>Piraino</surname><given-names>T</given-names></name><name><surname>Lima</surname><given-names>CAS</given-names></name><name><surname>Kavanagh</surname><given-names>BP</given-names></name><name><surname>Amato</surname><given-names>MBP</given-names></name><name><surname>Brochard</surname><given-names>L</given-names></name></person-group><article-title>Regional ventilation displayed by electrical impedance tomography as an incentive to decrease positive End-Expiratory pressure</article-title><source>Am J Respir Crit Care Med</source><year>2019</year><volume>200</volume><issue>7</issue><fpage>933</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1164/rccm.201904-0797LE</pub-id><pub-id pub-id-type="pmid">31225973</pub-id>
</element-citation><mixed-citation id="mc-CR25" publication-type="journal">Yoshida T, Piraino T, Lima CAS, Kavanagh BP, Amato MBP, Brochard L. Regional ventilation displayed by electrical impedance tomography as an incentive to decrease positive End-Expiratory pressure. Am J Respir Crit Care Med. 2019;200(7):933&#x02013;7.<pub-id pub-id-type="pmid">31225973</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name><surname>Scholten</surname><given-names>EL</given-names></name><name><surname>Beitler</surname><given-names>JR</given-names></name><name><surname>Prisk</surname><given-names>GK</given-names></name><name><surname>Malhotra</surname><given-names>A</given-names></name></person-group><article-title>Treatment of ARDS with prone positioning</article-title><source>Chest</source><year>2017</year><volume>151</volume><issue>1</issue><fpage>215</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1016/j.chest.2016.06.032</pub-id><pub-id pub-id-type="pmid">27400909</pub-id>
</element-citation><mixed-citation id="mc-CR26" publication-type="journal">Scholten EL, Beitler JR, Prisk GK, Malhotra A. Treatment of ARDS with prone positioning. Chest. 2017;151(1):215&#x02013;24.<pub-id pub-id-type="pmid">27400909</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Zhong</surname><given-names>M</given-names></name></person-group><article-title>Time-dependent effect of prone position in ARDS: considerations for future research</article-title><source>Crit Care</source><year>2024</year><volume>28</volume><issue>1</issue><fpage>129</fpage><pub-id pub-id-type="doi">10.1186/s13054-024-04915-1</pub-id><pub-id pub-id-type="pmid">38637901</pub-id>
</element-citation><mixed-citation id="mc-CR27" publication-type="journal">Wang Y, Zhong M. Time-dependent effect of prone position in ARDS: considerations for future research. Crit Care. 2024;28(1):129.<pub-id pub-id-type="pmid">38637901</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name><surname>Pappert</surname><given-names>D</given-names></name><name><surname>Rossaint</surname><given-names>R</given-names></name><name><surname>Slama</surname><given-names>K</given-names></name><name><surname>Gruning</surname><given-names>T</given-names></name><name><surname>Falke</surname><given-names>KJ</given-names></name></person-group><article-title>Influence of positioning on ventilation-perfusion relationships in severe adult respiratory distress syndrome</article-title><source>Chest</source><year>1994</year><volume>106</volume><issue>5</issue><fpage>1511</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1378/chest.106.5.1511</pub-id><pub-id pub-id-type="pmid">7956412</pub-id>
</element-citation><mixed-citation id="mc-CR28" publication-type="journal">Pappert D, Rossaint R, Slama K, Gruning T, Falke KJ. Influence of positioning on ventilation-perfusion relationships in severe adult respiratory distress syndrome. Chest. 1994;106(5):1511&#x02013;6.<pub-id pub-id-type="pmid">7956412</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>CM</given-names></name><name><surname>Kim</surname><given-names>EK</given-names></name><name><surname>Lee</surname><given-names>JS</given-names></name><name><surname>Shim</surname><given-names>TS</given-names></name><name><surname>Lee</surname><given-names>SD</given-names></name><name><surname>Koh</surname><given-names>Y</given-names></name><name><surname>Kim</surname><given-names>WS</given-names></name><name><surname>Kim</surname><given-names>DS</given-names></name><name><surname>Kim</surname><given-names>WD</given-names></name></person-group><article-title>Comparison of the response to the prone position between pulmonary and extrapulmonary acute respiratory distress syndrome</article-title><source>Intensive Care Med</source><year>2001</year><volume>27</volume><issue>3</issue><fpage>477</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1007/s001340000848</pub-id><pub-id pub-id-type="pmid">11355115</pub-id>
</element-citation><mixed-citation id="mc-CR29" publication-type="journal">Lim CM, Kim EK, Lee JS, Shim TS, Lee SD, Koh Y, Kim WS, Kim DS, Kim WD. Comparison of the response to the prone position between pulmonary and extrapulmonary acute respiratory distress syndrome. Intensive Care Med. 2001;27(3):477&#x02013;85.<pub-id pub-id-type="pmid">11355115</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name><surname>Pelosi</surname><given-names>P</given-names></name><name><surname>D&#x02019;Onofrio</surname><given-names>D</given-names></name><name><surname>Chiumello</surname><given-names>D</given-names></name><name><surname>Paolo</surname><given-names>S</given-names></name><name><surname>Chiara</surname><given-names>G</given-names></name><name><surname>Capelozzi</surname><given-names>VL</given-names></name><name><surname>Barbas</surname><given-names>CS</given-names></name><name><surname>Chiaranda</surname><given-names>M</given-names></name><name><surname>Gattinoni</surname><given-names>L</given-names></name></person-group><article-title>Pulmonary and extrapulmonary acute respiratory distress syndrome are different</article-title><source>Eur Respir J Suppl</source><year>2003</year><volume>42</volume><fpage>s48</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1183/09031936.03.00420803</pub-id></element-citation><mixed-citation id="mc-CR30" publication-type="journal">Pelosi P, D&#x02019;Onofrio D, Chiumello D, Paolo S, Chiara G, Capelozzi VL, Barbas CS, Chiaranda M, Gattinoni L. Pulmonary and extrapulmonary acute respiratory distress syndrome are different. Eur Respir J Suppl. 2003;42:s48&#x02013;56.</mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name><surname>Richter</surname><given-names>T</given-names></name><name><surname>Bellani</surname><given-names>G</given-names></name><name><surname>Scott Harris</surname><given-names>R</given-names></name><name><surname>Vidal Melo</surname><given-names>MF</given-names></name><name><surname>Winkler</surname><given-names>T</given-names></name><name><surname>Venegas</surname><given-names>JG</given-names></name><name><surname>Musch</surname><given-names>G</given-names></name></person-group><article-title>Effect of prone position on regional shunt, aeration, and perfusion in experimental acute lung injury</article-title><source>Am J Respir Crit Care Med</source><year>2005</year><volume>172</volume><issue>4</issue><fpage>480</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1164/rccm.200501-004OC</pub-id><pub-id pub-id-type="pmid">15901611</pub-id>
</element-citation><mixed-citation id="mc-CR31" publication-type="journal">Richter T, Bellani G, Scott Harris R, Vidal Melo MF, Winkler T, Venegas JG, Musch G. Effect of prone position on regional shunt, aeration, and perfusion in experimental acute lung injury. Am J Respir Crit Care Med. 2005;172(4):480&#x02013;7.<pub-id pub-id-type="pmid">15901611</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>X</given-names></name><name><surname>Zhao</surname><given-names>Z</given-names></name><name><surname>Chao</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>D</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>R</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Xie</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Qiu</surname><given-names>H</given-names></name><etal/></person-group><article-title>Effects of early versus delayed application of prone position on ventilation-perfusion mismatch in patients with acute respiratory distress syndrome: a prospective observational study</article-title><source>Crit Care</source><year>2023</year><volume>27</volume><issue>1</issue><fpage>462</fpage><pub-id pub-id-type="doi">10.1186/s13054-023-04749-3</pub-id><pub-id pub-id-type="pmid">38012731</pub-id>
</element-citation><mixed-citation id="mc-CR32" publication-type="journal">Yuan X, Zhao Z, Chao Y, Chen D, Chen H, Zhang R, Liu S, Xie J, Yang Y, Qiu H, et al. Effects of early versus delayed application of prone position on ventilation-perfusion mismatch in patients with acute respiratory distress syndrome: a prospective observational study. Crit Care. 2023;27(1):462.<pub-id pub-id-type="pmid">38012731</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name><surname>Cressoni</surname><given-names>M</given-names></name><name><surname>Chiumello</surname><given-names>D</given-names></name><name><surname>Algieri</surname><given-names>I</given-names></name><name><surname>Brioni</surname><given-names>M</given-names></name><name><surname>Chiurazzi</surname><given-names>C</given-names></name><name><surname>Colombo</surname><given-names>A</given-names></name><name><surname>Colombo</surname><given-names>A</given-names></name><name><surname>Crimella</surname><given-names>F</given-names></name><name><surname>Guanziroli</surname><given-names>M</given-names></name><name><surname>Tomic</surname><given-names>I</given-names></name><etal/></person-group><article-title>Opening pressures and atelectrauma in acute respiratory distress syndrome</article-title><source>Intensive Care Med</source><year>2017</year><volume>43</volume><issue>5</issue><fpage>603</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1007/s00134-017-4754-8</pub-id><pub-id pub-id-type="pmid">28283699</pub-id>
</element-citation><mixed-citation id="mc-CR33" publication-type="journal">Cressoni M, Chiumello D, Algieri I, Brioni M, Chiurazzi C, Colombo A, Colombo A, Crimella F, Guanziroli M, Tomic I, et al. Opening pressures and atelectrauma in acute respiratory distress syndrome. Intensive Care Med. 2017;43(5):603&#x02013;11.<pub-id pub-id-type="pmid">28283699</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name><surname>Terragni</surname><given-names>PP</given-names></name><name><surname>Rosboch</surname><given-names>G</given-names></name><name><surname>Tealdi</surname><given-names>A</given-names></name><name><surname>Corno</surname><given-names>E</given-names></name><name><surname>Menaldo</surname><given-names>E</given-names></name><name><surname>Davini</surname><given-names>O</given-names></name><name><surname>Gandini</surname><given-names>G</given-names></name><name><surname>Herrmann</surname><given-names>P</given-names></name><name><surname>Mascia</surname><given-names>L</given-names></name><name><surname>Quintel</surname><given-names>M</given-names></name><etal/></person-group><article-title>Tidal hyperinflation during low tidal volume ventilation in acute respiratory distress syndrome</article-title><source>Am J Respir Crit Care Med</source><year>2007</year><volume>175</volume><issue>2</issue><fpage>160</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1164/rccm.200607-915OC</pub-id><pub-id pub-id-type="pmid">17038660</pub-id>
</element-citation><mixed-citation id="mc-CR34" publication-type="journal">Terragni PP, Rosboch G, Tealdi A, Corno E, Menaldo E, Davini O, Gandini G, Herrmann P, Mascia L, Quintel M, et al. Tidal hyperinflation during low tidal volume ventilation in acute respiratory distress syndrome. Am J Respir Crit Care Med. 2007;175(2):160&#x02013;6.<pub-id pub-id-type="pmid">17038660</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name><surname>Gattinoni</surname><given-names>L</given-names></name><name><surname>Collino</surname><given-names>F</given-names></name><name><surname>Camporota</surname><given-names>L</given-names></name></person-group><article-title>Ventilator induced lung injury: a case for a larger umbrella?</article-title><source>Intensive Care Med</source><year>2024</year><volume>50</volume><issue>2</issue><fpage>275</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1007/s00134-023-07296-1</pub-id><pub-id pub-id-type="pmid">38172299</pub-id>
</element-citation><mixed-citation id="mc-CR35" publication-type="journal">Gattinoni L, Collino F, Camporota L. Ventilator induced lung injury: a case for a larger umbrella? Intensive Care Med. 2024;50(2):275&#x02013;8.<pub-id pub-id-type="pmid">38172299</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name><surname>Slutsky</surname><given-names>AS</given-names></name><name><surname>Ranieri</surname><given-names>VM</given-names></name></person-group><article-title>Ventilator-induced lung injury</article-title><source>N Engl J Med</source><year>2013</year><volume>369</volume><issue>22</issue><fpage>2126</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1056/NEJMra1208707</pub-id><pub-id pub-id-type="pmid">24283226</pub-id>
</element-citation><mixed-citation id="mc-CR36" publication-type="journal">Slutsky AS, Ranieri VM. Ventilator-induced lung injury. N Engl J Med. 2013;369(22):2126&#x02013;36.<pub-id pub-id-type="pmid">24283226</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name><surname>Spinelli</surname><given-names>E</given-names></name><name><surname>Kircher</surname><given-names>M</given-names></name><name><surname>Stender</surname><given-names>B</given-names></name><name><surname>Ottaviani</surname><given-names>I</given-names></name><name><surname>Basile</surname><given-names>MC</given-names></name><name><surname>Marongiu</surname><given-names>I</given-names></name><name><surname>Colussi</surname><given-names>G</given-names></name><name><surname>Grasselli</surname><given-names>G</given-names></name><name><surname>Pesenti</surname><given-names>A</given-names></name><name><surname>Mauri</surname><given-names>T</given-names></name></person-group><article-title>Unmatched ventilation and perfusion measured by electrical impedance tomography predicts the outcome of ARDS</article-title><source>Crit Care</source><year>2021</year><volume>25</volume><issue>1</issue><fpage>192</fpage><pub-id pub-id-type="doi">10.1186/s13054-021-03615-4</pub-id><pub-id pub-id-type="pmid">34082795</pub-id>
</element-citation><mixed-citation id="mc-CR37" publication-type="journal">Spinelli E, Kircher M, Stender B, Ottaviani I, Basile MC, Marongiu I, Colussi G, Grasselli G, Pesenti A, Mauri T. Unmatched ventilation and perfusion measured by electrical impedance tomography predicts the outcome of ARDS. Crit Care. 2021;25(1):192.<pub-id pub-id-type="pmid">34082795</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38.</label><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name><surname>Guerin</surname><given-names>C</given-names></name><name><surname>Albert</surname><given-names>RK</given-names></name><name><surname>Beitler</surname><given-names>J</given-names></name><name><surname>Gattinoni</surname><given-names>L</given-names></name><name><surname>Jaber</surname><given-names>S</given-names></name><name><surname>Marini</surname><given-names>JJ</given-names></name><name><surname>Munshi</surname><given-names>L</given-names></name><name><surname>Papazian</surname><given-names>L</given-names></name><name><surname>Pesenti</surname><given-names>A</given-names></name><name><surname>Vieillard-Baron</surname><given-names>A</given-names></name><etal/></person-group><article-title>Prone position in ARDS patients: why, when, how and for whom</article-title><source>Intensive Care Med</source><year>2020</year><volume>46</volume><issue>12</issue><fpage>2385</fpage><lpage>96</lpage><pub-id pub-id-type="doi">10.1007/s00134-020-06306-w</pub-id><pub-id pub-id-type="pmid">33169218</pub-id>
</element-citation><mixed-citation id="mc-CR38" publication-type="journal">Guerin C, Albert RK, Beitler J, Gattinoni L, Jaber S, Marini JJ, Munshi L, Papazian L, Pesenti A, Vieillard-Baron A, et al. Prone position in ARDS patients: why, when, how and for whom. Intensive Care Med. 2020;46(12):2385&#x02013;96.<pub-id pub-id-type="pmid">33169218</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR39"><label>39.</label><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name><surname>Guerin</surname><given-names>C</given-names></name><name><surname>Beuret</surname><given-names>P</given-names></name><name><surname>Constantin</surname><given-names>JM</given-names></name><name><surname>Bellani</surname><given-names>G</given-names></name><name><surname>Garcia-Olivares</surname><given-names>P</given-names></name><name><surname>Roca</surname><given-names>O</given-names></name><name><surname>Meertens</surname><given-names>JH</given-names></name><name><surname>Maia</surname><given-names>PA</given-names></name><name><surname>Becher</surname><given-names>T</given-names></name><name><surname>Peterson</surname><given-names>J</given-names></name><etal/></person-group><article-title>A prospective international observational prevalence study on prone positioning of ARDS patients: the APRONET (ARDS prone position Network) study</article-title><source>Intensive Care Med</source><year>2018</year><volume>44</volume><issue>1</issue><fpage>22</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1007/s00134-017-4996-5</pub-id><pub-id pub-id-type="pmid">29218379</pub-id>
</element-citation><mixed-citation id="mc-CR39" publication-type="journal">Guerin C, Beuret P, Constantin JM, Bellani G, Garcia-Olivares P, Roca O, Meertens JH, Maia PA, Becher T, Peterson J, et al. A prospective international observational prevalence study on prone positioning of ARDS patients: the APRONET (ARDS prone position Network) study. Intensive Care Med. 2018;44(1):22&#x02013;37.<pub-id pub-id-type="pmid">29218379</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR40"><label>40.</label><citation-alternatives><element-citation id="ec-CR40" publication-type="journal"><person-group person-group-type="author"><name><surname>Bellani</surname><given-names>G</given-names></name><name><surname>Laffey</surname><given-names>JG</given-names></name><name><surname>Pham</surname><given-names>T</given-names></name><name><surname>Fan</surname><given-names>E</given-names></name><name><surname>Brochard</surname><given-names>L</given-names></name><name><surname>Esteban</surname><given-names>A</given-names></name><name><surname>Gattinoni</surname><given-names>L</given-names></name><name><surname>van Haren</surname><given-names>F</given-names></name><name><surname>Larsson</surname><given-names>A</given-names></name><name><surname>McAuley</surname><given-names>DF</given-names></name><etal/></person-group><article-title>Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries</article-title><source>JAMA</source><year>2016</year><volume>315</volume><issue>8</issue><fpage>788</fpage><lpage>800</lpage><pub-id pub-id-type="doi">10.1001/jama.2016.0291</pub-id><pub-id pub-id-type="pmid">26903337</pub-id>
</element-citation><mixed-citation id="mc-CR40" publication-type="journal">Bellani G, Laffey JG, Pham T, Fan E, Brochard L, Esteban A, Gattinoni L, van Haren F, Larsson A, McAuley DF, et al. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA. 2016;315(8):788&#x02013;800.<pub-id pub-id-type="pmid">26903337</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR41"><label>41.</label><citation-alternatives><element-citation id="ec-CR41" publication-type="journal"><person-group person-group-type="author"><name><surname>Amato</surname><given-names>MB</given-names></name><name><surname>Meade</surname><given-names>MO</given-names></name><name><surname>Slutsky</surname><given-names>AS</given-names></name><name><surname>Brochard</surname><given-names>L</given-names></name><name><surname>Costa</surname><given-names>EL</given-names></name><name><surname>Schoenfeld</surname><given-names>DA</given-names></name><name><surname>Stewart</surname><given-names>TE</given-names></name><name><surname>Briel</surname><given-names>M</given-names></name><name><surname>Talmor</surname><given-names>D</given-names></name><name><surname>Mercat</surname><given-names>A</given-names></name><etal/></person-group><article-title>Driving pressure and survival in the acute respiratory distress syndrome</article-title><source>N Engl J Med</source><year>2015</year><volume>372</volume><issue>8</issue><fpage>747</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1056/NEJMsa1410639</pub-id><pub-id pub-id-type="pmid">25693014</pub-id>
</element-citation><mixed-citation id="mc-CR41" publication-type="journal">Amato MB, Meade MO, Slutsky AS, Brochard L, Costa EL, Schoenfeld DA, Stewart TE, Briel M, Talmor D, Mercat A, et al. Driving pressure and survival in the acute respiratory distress syndrome. N Engl J Med. 2015;372(8):747&#x02013;55.<pub-id pub-id-type="pmid">25693014</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR42"><label>42.</label><citation-alternatives><element-citation id="ec-CR42" publication-type="journal"><person-group person-group-type="author"><name><surname>Glenny</surname><given-names>RW</given-names></name><name><surname>Lamm</surname><given-names>WJ</given-names></name><name><surname>Albert</surname><given-names>RK</given-names></name><name><surname>Robertson</surname><given-names>HT</given-names></name></person-group><article-title>Gravity is a minor determinant of pulmonary blood flow distribution</article-title><source>J Appl Physiol (1985)</source><year>1991</year><volume>71</volume><issue>2</issue><fpage>620</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1152/jappl.1991.71.2.620</pub-id><pub-id pub-id-type="pmid">1938736</pub-id>
</element-citation><mixed-citation id="mc-CR42" publication-type="journal">Glenny RW, Lamm WJ, Albert RK, Robertson HT. Gravity is a minor determinant of pulmonary blood flow distribution. J Appl Physiol (1985). 1991;71(2):620&#x02013;9.<pub-id pub-id-type="pmid">1938736</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR43"><label>43.</label><citation-alternatives><element-citation id="ec-CR43" publication-type="journal"><person-group person-group-type="author"><name><surname>Dunham-Snary</surname><given-names>KJ</given-names></name><name><surname>Wu</surname><given-names>D</given-names></name><name><surname>Sykes</surname><given-names>EA</given-names></name><name><surname>Thakrar</surname><given-names>A</given-names></name><name><surname>Parlow</surname><given-names>LRG</given-names></name><name><surname>Mewburn</surname><given-names>JD</given-names></name><name><surname>Parlow</surname><given-names>JL</given-names></name><name><surname>Archer</surname><given-names>SL</given-names></name></person-group><article-title>Hypoxic pulmonary vasoconstriction: from molecular mechanisms to medicine</article-title><source>Chest</source><year>2017</year><volume>151</volume><issue>1</issue><fpage>181</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1016/j.chest.2016.09.001</pub-id><pub-id pub-id-type="pmid">27645688</pub-id>
</element-citation><mixed-citation id="mc-CR43" publication-type="journal">Dunham-Snary KJ, Wu D, Sykes EA, Thakrar A, Parlow LRG, Mewburn JD, Parlow JL, Archer SL. Hypoxic pulmonary vasoconstriction: from molecular mechanisms to medicine. Chest. 2017;151(1):181&#x02013;92.<pub-id pub-id-type="pmid">27645688</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR44"><label>44.</label><citation-alternatives><element-citation id="ec-CR44" publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>H</given-names></name><name><surname>Chi</surname><given-names>Y</given-names></name><name><surname>Long</surname><given-names>Y</given-names></name><name><surname>Yuan</surname><given-names>S</given-names></name><name><surname>Frerichs</surname><given-names>I</given-names></name><name><surname>Moller</surname><given-names>K</given-names></name><name><surname>Fu</surname><given-names>F</given-names></name><name><surname>Zhao</surname><given-names>Z</given-names></name></person-group><article-title>Influence of overdistension/recruitment induced by high positive end-expiratory pressure on ventilation-perfusion matching assessed by electrical impedance tomography with saline bolus</article-title><source>Crit Care</source><year>2020</year><volume>24</volume><issue>1</issue><fpage>586</fpage><pub-id pub-id-type="doi">10.1186/s13054-020-03301-x</pub-id><pub-id pub-id-type="pmid">32993811</pub-id>
</element-citation><mixed-citation id="mc-CR44" publication-type="journal">He H, Chi Y, Long Y, Yuan S, Frerichs I, Moller K, Fu F, Zhao Z. Influence of overdistension/recruitment induced by high positive end-expiratory pressure on ventilation-perfusion matching assessed by electrical impedance tomography with saline bolus. Crit Care. 2020;24(1):586.<pub-id pub-id-type="pmid">32993811</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR45"><label>45.</label><citation-alternatives><element-citation id="ec-CR45" publication-type="journal"><person-group person-group-type="author"><name><surname>Combes</surname><given-names>A</given-names></name><name><surname>Hajage</surname><given-names>D</given-names></name><name><surname>Capellier</surname><given-names>G</given-names></name><name><surname>Demoule</surname><given-names>A</given-names></name><name><surname>Lavoue</surname><given-names>S</given-names></name><name><surname>Guervilly</surname><given-names>C</given-names></name><name><surname>Da Silva</surname><given-names>D</given-names></name><name><surname>Zafrani</surname><given-names>L</given-names></name><name><surname>Tirot</surname><given-names>P</given-names></name><name><surname>Veber</surname><given-names>B</given-names></name><etal/></person-group><article-title>Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome</article-title><source>N Engl J Med</source><year>2018</year><volume>378</volume><issue>21</issue><fpage>1965</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1800385</pub-id><pub-id pub-id-type="pmid">29791822</pub-id>
</element-citation><mixed-citation id="mc-CR45" publication-type="journal">Combes A, Hajage D, Capellier G, Demoule A, Lavoue S, Guervilly C, Da Silva D, Zafrani L, Tirot P, Veber B, et al. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. N Engl J Med. 2018;378(21):1965&#x02013;75.<pub-id pub-id-type="pmid">29791822</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR46"><label>46.</label><citation-alternatives><element-citation id="ec-CR46" publication-type="journal"><person-group person-group-type="author"><name><surname>Griffiths</surname><given-names>MJ</given-names></name><name><surname>Evans</surname><given-names>TW</given-names></name></person-group><article-title>Inhaled nitric oxide therapy in adults</article-title><source>N Engl J Med</source><year>2005</year><volume>353</volume><issue>25</issue><fpage>2683</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1056/NEJMra051884</pub-id><pub-id pub-id-type="pmid">16371634</pub-id>
</element-citation><mixed-citation id="mc-CR46" publication-type="journal">Griffiths MJ, Evans TW. Inhaled nitric oxide therapy in adults. N Engl J Med. 2005;353(25):2683&#x02013;95.<pub-id pub-id-type="pmid">16371634</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR47"><label>47.</label><citation-alternatives><element-citation id="ec-CR47" publication-type="journal"><person-group person-group-type="author"><name><surname>Tuffet</surname><given-names>S</given-names></name><name><surname>Maraffi</surname><given-names>T</given-names></name><name><surname>Lacheny</surname><given-names>M</given-names></name><name><surname>Perier</surname><given-names>F</given-names></name><name><surname>Haudebourg</surname><given-names>AF</given-names></name><name><surname>Boujelben</surname><given-names>MA</given-names></name><name><surname>Alcala</surname><given-names>G</given-names></name><name><surname>Mekontso-Dessap</surname><given-names>A</given-names></name><name><surname>Carteaux</surname><given-names>G</given-names></name></person-group><article-title>Impact of cardiac output and alveolar ventilation in estimating ventilation/perfusion mismatch in ARDS using electrical impedance tomography</article-title><source>Crit Care</source><year>2023</year><volume>27</volume><issue>1</issue><fpage>176</fpage><pub-id pub-id-type="doi">10.1186/s13054-023-04467-w</pub-id><pub-id pub-id-type="pmid">37158963</pub-id>
</element-citation><mixed-citation id="mc-CR47" publication-type="journal">Tuffet S, Maraffi T, Lacheny M, Perier F, Haudebourg AF, Boujelben MA, Alcala G, Mekontso-Dessap A, Carteaux G. Impact of cardiac output and alveolar ventilation in estimating ventilation/perfusion mismatch in ARDS using electrical impedance tomography. Crit Care. 2023;27(1):176.<pub-id pub-id-type="pmid">37158963</pub-id>
</mixed-citation></citation-alternatives></ref></ref-list></back></article>